<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Appl Environ Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Appl Environ Microbiol</journal-id><journal-id journal-id-type="publisher-id">aem</journal-id><journal-title-group><journal-title>Applied and Environmental Microbiology</journal-title></journal-title-group><issn pub-type="ppub">0099-2240</issn><issn pub-type="epub">1098-5336</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40272117</article-id><article-id pub-id-type="pmc">PMC12094015</article-id>
<article-id pub-id-type="publisher-id">aem00010-25</article-id><article-id pub-id-type="doi">10.1128/aem.00010-25</article-id><article-id pub-id-type="publisher-id">aem.00010-25</article-id><article-categories><subj-group subj-group-type="heading"><subject>Evolutionary and Genomic Microbiology</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">microbial-genetics</compound-subject-part><compound-subject-part content-type="label">Microbial Genetics</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Population and pan-genomic analyses of <italic toggle="yes">Staphylococcus pseudintermedius</italic> identify geographic distinctions in accessory gene content and novel loci associated with AMR</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2099-4172</contrib-id><name><surname>Zehr</surname><given-names>Jordan D.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Qi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Ceres</surname><given-names>Kristina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Merrill</surname><given-names>Amy</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2729-5035</contrib-id><name><surname>Tyson</surname><given-names>Gregory H.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Ceric</surname><given-names>Olgica</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Guag</surname><given-names>Jake</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Pauley</surname><given-names>Sarah</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>McQueary</surname><given-names>Holly C.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Sams</surname><given-names>Kelly</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Reboul</surname><given-names>Guillaume</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Patrick K.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Renee</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Franklin-Guild</surname><given-names>Rebecca</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Guarino</surname><given-names>Cassandra</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Cronk</surname><given-names>Brittany D.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Burbick</surname><given-names>Claire R.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Wolking</surname><given-names>Rebecca</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Peak</surname><given-names>Laura</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yan</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="pa1" ref-type="author-notes"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>McDowall</surname><given-names>Rebeccah</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Krishnamurthy</surname><given-names>Aparna</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Slavic</surname><given-names>Durda</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Sekhon</surname><given-names>Prabhjot Kaur</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="pa2" ref-type="author-notes"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Needle</surname><given-names>David</given-names></name><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Gibson</surname><given-names>Robert</given-names></name><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Cazer</surname><given-names>Casey</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Jennifer</given-names></name><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2355-8707</contrib-id><name><surname>Harris</surname><given-names>Beth</given-names></name><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4590-1529</contrib-id><name><surname>Stanhope</surname><given-names>Michael J.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8327-3092</contrib-id><name><surname>Goodman</surname><given-names>Laura B.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role><email>laura.goodman@cornell.edu</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Cornell University</institution><institution-id institution-id-type="Ringgold">5922</institution-id><institution-id institution-id-type="ROR">https://ror.org/05bnh6r87</institution-id></institution-wrap>, <city>Ithaca</city>, <state>New York</state>, <country>USA</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Office of Applied Science, Center for Veterinary Medicine, US Food and Drug Administration</institution><institution-id institution-id-type="Ringgold">621252</institution-id><institution-id institution-id-type="ROR">https://ror.org/02y55wr53</institution-id></institution-wrap>, <city>Rockville</city>, <state>Maryland</state>, <country>USA</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution>Washington Animal Disease Diagnostic Laboratory, Washington State University</institution><institution-id institution-id-type="Ringgold">6760</institution-id><institution-id institution-id-type="ROR">https://ror.org/05dk0ce17</institution-id></institution-wrap>, <city>Pullman</city>, <state>Washington</state>, <country>USA</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution>Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University</institution><institution-id institution-id-type="Ringgold">70164</institution-id><institution-id institution-id-type="ROR">https://ror.org/05ect4e57</institution-id></institution-wrap>, <city>Baton Rouge</city>, <state>Louisiana</state>, <country>USA</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution>Ohio Department of Agriculture Animal Disease Diagnostic Laboratory</institution><institution-id institution-id-type="Ringgold">207837</institution-id><institution-id institution-id-type="ROR">https://ror.org/00xspzv28</institution-id></institution-wrap>, <city>Reynoldsburg</city>, <state>Ohio</state>, <country>USA</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution>Animal Health Laboratory, University of Guelph</institution><institution-id institution-id-type="Ringgold">3653</institution-id><institution-id institution-id-type="ROR">https://ror.org/01r7awg59</institution-id></institution-wrap>, <city>Guelph</city>, <state>Ontario</state>, <country>Canada</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution>South Dakota State University</institution><institution-id institution-id-type="ROR">https://ror.org/015jmes13</institution-id></institution-wrap>, <city>Brookings</city>, <state>South Dakota</state>, <country>USA</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution>Veterinary Diagnostic Laboratory, University of New Hampshire</institution><institution-id institution-id-type="Ringgold">3067</institution-id><institution-id institution-id-type="ROR">https://ror.org/01rmh9n78</institution-id></institution-wrap>, <city>Durham</city>, <state>New Hampshire</state>, <country>USA</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution>USDA APHIS National Animal Health Laboratory Network</institution></institution-wrap>, <city>Ames</city>, <state>Iowa</state>, <country>USA</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Elkins</surname><given-names>Christopher A.</given-names></name><aff><institution-wrap><institution>Centers for Disease Control and Prevention</institution></institution-wrap>, <city>Atlanta</city>, <state>Georgia</state>, <country>USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Laura B. Goodman, <email xlink:href="mailto:laura.goodman@cornell.edu">laura.goodman@cornell.edu</email></corresp><fn fn-type="present-address" id="pa1"><p>Present address: Arizona Veterinary Diagnostic Laboratory, Tucson, Arizona, USA</p></fn><fn fn-type="present-address" id="pa2"><p>Present address: Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA</p></fn><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>5</month><year>2025</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>4</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>91</volume><issue>5</issue><elocation-id>e00010-25</elocation-id><history>
<date date-type="received"><day>02</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>17</day><month>3</month><year>2025</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2025 Zehr et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Zehr et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-04-24"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="aem.00010-25.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p><italic toggle="yes">Staphylococcus pseudintermedius</italic> is a common representative of the normal skin microbiota of dogs and cats but is also a causative agent of a variety of infections. Although primarily a canine/feline bacterium, recent studies suggest an expanded host range including humans. This paper details population genomic analyses of the largest yet assembled and sequenced collection of <italic toggle="yes">S. pseudintermedius</italic> isolates from across the USA and Canada and assesses these isolates within a larger global population genetic context. We then employ a pan-genome-wide association study analysis of over 1,700 <italic toggle="yes">S</italic>. <italic toggle="yes">pseudintermedius</italic> isolates from sick dogs and cats, covering the period 2017&#x02013;2020, correlating loci at a genome-wide level, with <italic toggle="yes">in vitro</italic> susceptibility data for 23 different antibiotics. We find no evidence from either core genome phylogenies or accessory genome content for separate lineages colonizing cats or dogs. Some core genome geographic clustering was evident on a global scale, and accessory gene content was noticeably different between various regions, some of which could be linked to known antimicrobial resistance (AMR) loci for certain classes of antibiotics (e.g., aminoglycosides). Analysis of genes correlated with AMR was divided into different categories, depending on whether they were known resistance mechanisms, on a plasmid, or a putatively novel resistance mechanism on the chromosome. We discuss several novel chromosomal candidates for follow-up laboratory experimentation, including, for example, a bacteriocin (subtilosin), for which the same protein from <italic toggle="yes">Bacillus subtilis</italic> has been shown to be active against <italic toggle="yes">Staphylococcus aureus</italic> infections, and for which the operon, present in closely related <italic toggle="yes">Staphylococcus</italic> species, is absent in <italic toggle="yes">S. aureus</italic>.</p><sec><title>IMPORTANCE</title><p><italic toggle="yes">Staphylococcus pseudintermedius</italic> is an important causative agent of a variety of canine and feline infections, with recent studies suggesting an expanded host range, including humans. This paper presents global population genomic data and analysis of the largest set yet sequenced for this organism, covering the USA and Canada as well as more globally. It also presents analysis of <italic toggle="yes">in vitro</italic> antibiotic susceptibility testing results for the North American (NA) isolates, as well as genetic analysis for the global set. We conduct a pan-genome-wide association study analysis of over 1,700 S. <italic toggle="yes">pseudintermedius</italic> isolates from sick dogs and cats from NA to correlate loci at a genome-wide level with the <italic toggle="yes">in vitro</italic> susceptibility data for 23 different antibiotics. We discuss several chromosomal loci arising from this analysis for follow-up laboratory experimentation. This study should provide insight regarding the development of novel molecular treatments for an organism of both veterinary and, increasingly, human medical concern.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd>antibiotic resistance</kwd><kwd><italic toggle="yes">Staphylococcus pseudintermedius</italic></kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>1U18FD006993</award-id><principal-award-recipient>
<name><surname>Stanhope</surname><given-names>Michael J.</given-names></name>
<name><surname>Goodman</surname><given-names>Laura B.</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-2"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>1U18FD006442</award-id><principal-award-recipient>
<name><surname>Peak</surname><given-names>Laura</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-3"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>1U18FD006712</award-id><principal-award-recipient>
<name><surname>Zhang</surname><given-names>Yan</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-4"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>1U18FD006862, 1U18FD007244</award-id><principal-award-recipient>
<name><surname>McDowall</surname><given-names>Rebeccah</given-names></name>
<name><surname>Krishnamurthy</surname><given-names>Aparna</given-names></name>
<name><surname>Slavic</surname><given-names>Durda</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-5"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>1U18FD006558</award-id><principal-award-recipient>
<name><surname>Sekhon</surname><given-names>Prabhjot Kaur</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-6"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>1U18FD006453</award-id><principal-award-recipient>
<name><surname>Burbick</surname><given-names>Claire R.</given-names></name>
<name><surname>Wolking</surname><given-names>Rebecca</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-7"><funding-source>
<institution-wrap><institution>U.S. Food and Drug Administration</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000038</institution-id></institution-wrap>
</funding-source><award-id>5U18FD006716</award-id><principal-award-recipient>
<name><surname>Goodman</surname><given-names>Laura B.</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-8"><funding-source>
<institution-wrap><institution>U.S. Department of Agriculture</institution><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000199</institution-id></institution-wrap>
</funding-source><award-id>AP20VSD&#x00026;B000C018</award-id><principal-award-recipient>
<name><surname>Goodman</surname><given-names>Laura B.</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="8" count-type="supplementary-material"/><count count-type="authors" count="31"/><fig-count count="11"/><table-count count="1"/><ref-count count="75"/><page-count count="21"/><word-count count="11803"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p><italic toggle="yes">Staphylococcus pseudintermedius</italic> is a coagulase-positive species (CoPS) within the <italic toggle="yes">Staphylococcus intermedius</italic> group, which also includes the three CoPS species, <italic toggle="yes">Staphylococcus delphini</italic>, <italic toggle="yes">Staphylococcus intermedius</italic>, <italic toggle="yes">Staphylococcus cornubiensis</italic>, and a coagulase-negative species (CoNS), <italic toggle="yes">Staphylococcus ursi. S. pseudintermedius</italic> is a component of the normal skin microbiota of dogs but is also an important causative agent of skin infections such as canine pyoderma and surgical wound infections, as well as ear and urinary tract infections (<xref rid="B1" ref-type="bibr">1</xref>). Carriage rates of <italic toggle="yes">S. pseudintermedius</italic> in non-canine animal species such as cats and horses are much lower but still linked to pyoderma in both these hosts (<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">&#x02013;</xref><xref rid="B4" ref-type="bibr">4</xref>).</p><p>Much of the recent research interest on <italic toggle="yes">S. pseudintermedius</italic> has centered on the identification of methicillin-resistant (MRSP) strains and the zoonotic potential of the species (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). MRSP strains have higher non-susceptibility rates to all antimicrobials compared to methicillin-susceptible <italic toggle="yes">S. pseudintermedius</italic> (MSSP) (<xref rid="B7" ref-type="bibr">7</xref>), and the overall presence of MRSP in humans is increasing (<xref rid="B6" ref-type="bibr">6</xref>). MSSP isolates are often also resistant to at least three classes of antimicrobials, that is, multidrug resistant (MDR). Calabro et al. (<xref rid="B7" ref-type="bibr">7</xref>) found 47% prevalence overall for MDR in a survey of 1,804 isolates tested by one US reference laboratory. In another recent study of <italic toggle="yes">S. pseudintermedius</italic> in the New England area, Bruce et al. (<xref rid="B8" ref-type="bibr">8</xref>) found that out of 171 isolates tested, 41 were MRSP, 130 were MSSP, and 80 were MDR. Such high and increasing levels of antibiotic resistance represent a significant current and future challenge for the veterinary community (<xref rid="B9" ref-type="bibr">9</xref>), as well as an important consideration in the treatment of human zoonotic infections (<xref rid="B6" ref-type="bibr">6</xref>).</p><p>Many genes have been identified from a wide range of bacterial species that are causatively linked to antimicrobial resistance (AMR), and these are cataloged on resistance databases such as the Comprehensive Antibiotic Resistance Database (<xref rid="B10" ref-type="bibr">10</xref>) and AMRFinderPlus (<xref rid="B11" ref-type="bibr">11</xref>). Despite progress in identifying AMR loci, many yet unidentified genes conferring resistance undoubtedly form the repertoire of resistance mechanisms in most bacteria species. A significant body of information is known about AMR mechanisms in the important human pathogen <italic toggle="yes">Staphylococcus aureus</italic> (reviewed in reference <xref rid="B12" ref-type="bibr">12</xref>), and much of these loci are orthologous in <italic toggle="yes">S. pseudintermedius</italic> and are assumed to function similarly in dogs and cats. However, few studies have attempted to identify novel AMR mechanisms in <italic toggle="yes">S. pseudintermedius</italic>. One way to attempt to identify novel AMR loci is to correlate phenotypic susceptibility data with loci from genome sequence data and then form short lists of genes with significant correlations and follow up with laboratory experiments. Following on from the discovery that bacteria genomes comprise both core and accessory components (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>) and the resulting field of bacteria pan-genomics, genome-wide association study (GWAS) methods for bacteria were developed that use the gene presence/absence typical of bacteria accessory genomes as the variable for genetic correlation (pan-GWAS) (<xref rid="B15" ref-type="bibr">15</xref>). Many of the known resistance genes in <italic toggle="yes">S. aureus</italic> belong to the accessory genome (55%), and among these, 47 (27%) have been identified within the Staphylococcal Cassette Chromosome mec (SCCmec), which is responsible for resistance against various classes of antibiotics (<xref rid="B16" ref-type="bibr">16</xref>). The majority of these same or very similar SCCmec elements are carried by <italic toggle="yes">S. pseudintermedius</italic> (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Based on work by our group (<xref rid="B19" ref-type="bibr">19</xref>) and others (<xref rid="B20" ref-type="bibr">20</xref>), current genomic-based prediction accuracy of the presence of known resistance loci (inclusive of resistance-determining mutations) is approximately 97%&#x02013;98% depending on the antimicrobial. In addition to these known AMR loci, we hypothesize that a pan-GWAS approach could identify as yet unknown, putative resistance-determining genes from the <italic toggle="yes">S. pseudintermedius</italic> accessory genome. Herein, we employ such an unbiased pan-GWAS approach to correlate the presence and absence of <italic toggle="yes">S. pseudintermedius</italic> genes with resistance phenotypes in dogs or cats.</p><p>This paper details our examination of population genomics, covering the North American (NA) region in a global context, as well as levels of AMR in the largest comparative genomic data set yet assembled for <italic toggle="yes">S. pseudintermedius</italic>. We then go on to employ a pan-GWAS perspective on <italic toggle="yes">S. pseudintermedius</italic> isolates from sick dogs and cats collected as part of the US National Action Plan for Combating Antibiotic-Resistant Bacteria (<ext-link xlink:href="https://www.hhs.gov/ash/advisory-committees/paccarb/working-groups/national-action-plan/index.html" ext-link-type="uri">https://www.hhs.gov/ash/advisory-committees/paccarb/working-groups/national-action-plan/index.html</ext-link>) and its surveillance for resistant bacteria in animals (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). The analyzed collection includes <italic toggle="yes">in vitro</italic> susceptibility data for 23 different antibiotics from over 1,700 isolates across multiple regions of the USA and Canada, covering the period 2017&#x02013;2020. We correlate loci, at a genome-wide level, with resistance/susceptibility data for this large set of antibiotics and shortlist encouraging loci for further experimental evaluation.</p></sec><sec sec-type="materials|methods" id="s2"><title>MATERIALS AND METHODS</title><sec id="s2-1"><title>Samples and genome sequencing</title><p>No research animals were used for this study. <italic toggle="yes">S. pseudintermedius</italic> cultures from dogs and cats in the USA and Canada were collected as part of two federal programs which monitor AMR profiles in animal pathogens routinely isolated by veterinary clinics and diagnostic laboratories. The US FDA Veterinary Laboratory Investigation and Response Network program (<xref rid="B21" ref-type="bibr">21</xref>) has a total of 30 participating animal diagnostic laboratories that save clinical (from a sick or deceased animal) <italic toggle="yes">S. pseudintermedius</italic> isolates from canine cases submitted each month by a veterinarian for diagnostic testing. Isolates were tested for <italic toggle="yes">in vitro</italic> susceptibility, cryopreserved in glycerol, anonymized of identifying information, and shipped to one of six assigned sequencing reference laboratories. Whole-genome shotgun sequencing was performed using Illumina chemistry (DNA Prep or Nextera XT library preparation) on the MiSeq platform. Genomes meeting standardized benchmarks (<xref rid="B23" ref-type="bibr">23</xref>) were uploaded to the National Center for Biotechnology Information (NCBI). The USDA APHIS NAHLN AMR Monitoring Program (<xref rid="B24" ref-type="bibr">24</xref>) has 36 participating laboratories saving both canine and feline diagnostic isolates. Isolates in this study were sequenced either by those laboratories or by the National Veterinary Services Laboratories, using the same methods and quality benchmarks.</p><p>Sample sources from the combined USDA-FDA surveillance set included skin or nailbed biopsies/swabs, wound/abscess swabs, ear swabs, respiratory fluid/tissue, urine, and blood, collected from 2017 to 2020 by five regional reference laboratories in Canada and 26 laboratories across the USA. All genome sequences from dogs and cats used for AMR pan-GWAS are available in the following NCBI BioProjects: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA314609/" ext-link-type="uri">PRJNA314609</ext-link> and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA510565" ext-link-type="uri">PRJNA510565</ext-link>.</p></sec><sec id="s2-2"><title>Antimicrobial susceptibility testing (AST)</title><p><italic toggle="yes">In vitro</italic> antimicrobial susceptibility data were provided by the participating veterinary diagnostic laboratories with the Sensititre platform (Thermo Fisher Scientific) for automated broth microdilution using veterinary commercial panels. Interpretations of susceptibility were performed in February 2023 and standardized using the breakpoints provided in <xref rid="T1" ref-type="table">Table 1</xref>, based on a consensus of CLSI Vet01S (6th ed., February 2023). Antibiotics were interpreted independently to identify putative mechanisms associated with resistance unique to each antibiotic, in contrast to clinical determination of resistance to one antibiotic based on the result of another (i.e., cefazolin resistance inference based on oxacillin resistance). Samples that either came from an unknown infection source or did not have an MIC value provided were omitted. All AST data were based on broth microdilution with minimum inhibitory concentration (MIC); any isolates tested by disk diffusion were excluded. The proportion of resistant samples was compared between geographic regions with Pearson&#x02019;s chi-squared tests using the prop.test function in the R stats package version 4.3.1, R version 4.3.1. If at least one proportion was significantly different from others (<italic toggle="yes">P</italic> &#x0003c; 0.05), pairwise comparisons were calculated with Bonferroni correction for multiple comparisons using the pairwise.prop.test function in the R stats package. Proportions were compared separately for samples resistant to greater than five antibiotic classes and samples resistant to three to five antibiotic classes (<xref rid="B25" ref-type="bibr">25</xref>). All MIC data are available in Excel format at <ext-link xlink:href="https://www.fda.gov/animal-veterinary/national-antimicrobial-resistance-monitoring-system/integrated-reportssummaries" ext-link-type="uri">https://www.fda.gov/animal-veterinary/national-antimicrobial-resistance-monitoring-system/integrated-reportssummaries</ext-link>.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Breakpoints used for binary coding of susceptibility phenotypes (resistant above identified breakpoint)<xref rid="T1_FN1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" valign="top" colspan="1" rowspan="1">Antibiotic</th><th align="left" valign="top" colspan="1" rowspan="1">Dog/cat</th><th align="left" valign="top" colspan="1" rowspan="1">Human</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Amikacin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;16</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Amoxicillin/clavulanic acid</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;1</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Ampicillin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;0.5</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cefazolin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;8</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cefovecin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;2</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cefpodoxime</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;8</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cephalothin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;8</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Chloramphenicol</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;32</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Clindamycin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;4</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Doxycycline</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;0.5</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Enrofloxacin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;4</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Erythromycin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;8</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Gentamicin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;16</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Marbofloxacin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;4</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Minocycline</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;2</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Nitrofurantoin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;128</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Oxacillin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;0.5</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Penicillin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;0.25</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Pradofloxacin</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;2</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Rifampin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;4</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Tetracycline</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;1</td><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Trimethoprim-sulfamethoxazole</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;4</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Vancomycin</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1">&#x02265;32</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN1"><label>
<sup>
<italic toggle="yes">a</italic>
</sup>
</label><p>Human breakpoints were used when neither dog nor cat breakpoints were available. MICs (&#x003bc;g/mL) meeting the reported breakpoint criteria for each antibiotic listed below are considered resistant, and otherwise are labeled as susceptible.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-3"><title>Genome assembly, phylogenetic reconstruction, population genetics</title><p>Genomes not already assembled by NCBI were assembled using SKESA (<xref rid="B26" ref-type="bibr">26</xref>). Assemblies with &#x0003e;200 contiguous sequences (contigs) and outliers from a multi-dimensional scaling plot created from Panaroo v.1.2.9 (<xref rid="B27" ref-type="bibr">27</xref>) QC step were excluded from downstream analysis. All NA genomes were verified to have either dog or cat indicated in the host metadata. The final curated set of compiled dog/cat <italic toggle="yes">S. pseudintermedius</italic> genomes for the NA set was 1,746 (1,584 dogs and 162 cats). To examine where these NAm isolates fit within a broader population genetic perspective, an additional data set was compiled of global isolates from NCBI; this final set included 2,933 genome sequences from dogs, 214 from cats, 59 from humans, and 473 of unknown host origin (<xref rid="SuF6" ref-type="supplementary-material">Table S1</xref> includes the number of genome sequences per country). Multilocus sequence typing was performed separately on both the NA and global data sets using mlst (<ext-link xlink:href="https://github.com/tseemann/mlst" ext-link-type="uri">https://github.com/tseemann/mlst</ext-link>) and the PubMLST database (<xref rid="B28" ref-type="bibr">28</xref>). Core genome alignments were generated with Panaroo v.1.2.9 (<xref rid="B27" ref-type="bibr">27</xref>) using the MAFFT algorithm (<xref rid="B29" ref-type="bibr">29</xref>). Gaps were then eliminated using Gblocks v.0.91b (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Trees were built using IQ-TREE v.2.0.3 (<xref rid="B32" ref-type="bibr">32</xref>) and iTOL (<xref rid="B33" ref-type="bibr">33</xref>). hierBAPS population genomic clustering was conducted using the R package RhierBAPS (<xref rid="B34" ref-type="bibr">34</xref>), employing the same multiple sequence alignments used for phylogenetic reconstruction.</p></sec><sec id="s2-4"><title>Pan-genomics, plasmid identification, and Scoary</title><p>Panaroo v.1.2.9 (<xref rid="B27" ref-type="bibr">27</xref>) was used to demarcate the <italic toggle="yes">S. pseudintermedius</italic> pan-genome for both the NA and global sets of data and to identify core and accessory genes for downstream analysis. The interpretation data were compiled and coded into binary data for each reported antibiotic (0 = susceptible; 1 = resistant), and Scoary v.1.6.16 (<xref rid="B15" ref-type="bibr">15</xref>) was used to correlate resistance phenotypes with accessory gene presence/absence. Genes judged to be correlated with resistance needed to pass both empirical <italic toggle="yes">P</italic>-value and Bonferroni correction, at <italic toggle="yes">P</italic> &#x0003c; 0.01. The &#x0201c;collapse&#x0201d; flag was added to the command line of Scoary runs, since this collapses genes that are identically distributed in the sample set. This is the recommended approach from a statistical perspective because, in the opposite case, the program would test multiple identical null hypotheses penalizing the results in terms of multiple comparisons correction. We focused our attention on identifying putative novel resistance genes that were chromosomal, so we first identified known AMR loci, as well as genes carried on plasmids, because plasmid-borne genes may simply be correlated with resistance due to linkage with a known AMR locus. Scoary significant genes were compared with known AMR determinants using AMRFinderPlus (<xref rid="B11" ref-type="bibr">11</xref>). Plasmids were identified using PlasmidFinder (<xref rid="B35" ref-type="bibr">35</xref>). Gene clusters identified with Panaroo were designated as plasmid-borne if &#x0003e;10% of the members of a given cluster were located on the predicted plasmids. This procedure resulted in categorizing the Scoary significant genes into the following four groups, where &#x0201c;plasmid&#x0201d; in the following categorizations excludes chromosomally integrated plasmids: (i) known AMR locus carried on a plasmid; (ii) on a plasmid but not a known AMR gene; (iii) known AMR gene not on a plasmid; (iv) not a known AMR gene and not on a plasmid. SCCmec cassettes were typed with Staphopia (<ext-link xlink:href="https://github.com/staphopia/staphopia-sccmec" ext-link-type="uri">github.com/staphopia/staphopia-sccmec</ext-link>) (<xref rid="B36" ref-type="bibr">36</xref>).</p></sec></sec><sec sec-type="results" id="s3"><title>RESULTS</title><sec id="s3-1"><title>Pan-genome, core-genome phylogeny, and population genetics</title><p>Pan-genomic components were determined separately for both the NA and global data sets. The data for both supported an open pan-genome with new genes being discovered with new genomes sequenced; the NA set peaked at 5,416 genes and had a core genome size of 1,963 (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). The complete pan-genomic statistics appear in <xref rid="F2" ref-type="fig">Fig. 2A</xref>. The combined cat/dog core genome alignment for the NA set was 1,962,770 bp before curation (Gblocks) and 734,143 bp after curation. The core-genome phylogeny did not support single distinct monophyletic groups of cat and dog isolates, or alternatively several distinct lineages of cat and dog isolates (<xref rid="F3" ref-type="fig">Fig. 3</xref>); instead, both host groups were entirely mixed. Principal component analysis (PCA) of the NA accessory gene content does not support a distinction in gene content between <italic toggle="yes">S. pseudintermedius</italic> isolated from the two different hosts (<xref rid="F4" ref-type="fig">Fig. 4A</xref>) or from geographic areas (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). MLST profiles for the NA set indicated that ST181 was the most common of typable isolates, followed by ST551 (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). This pattern repeated itself in the different geographic regions, with the exception of Canada, where ST181 was less dominant. An abundance of low copy (&#x02264;5 and &#x0003e;1) and singleton sequence types (STs) was apparent in this NA set. There were also a large number of isolates without ST assignment on the pubMLST database. For the NA set, this included 898 isolates, and of those, 839 were unique allelic combinations. We found 40 distinct genetic groups that had an <italic toggle="yes">N</italic> &#x0003e; 10 for each cluster using RhierBAPS at hierarchical level 2 clustering. Within each of these clusters, there were samples from multiple distinct geographic regions, indicating that population structure is not strongly related to geography (<xref rid="F6" ref-type="fig">Fig. 6A</xref>).</p><fig position="float" fig-type="figure" id="F1"><label>Fig 1</label><caption><p><italic toggle="yes">Staphylococcus pseudintermedius</italic> pan-genome curves. (<bold>A</bold>) FDA-USDA data set from North America. (<bold>B</bold>) Global data set inclusive of FDA-USDA.</p></caption><graphic xlink:href="aem.00010-25.f001" position="float"><alt-text>Two line graphs present core genome and pangenome clusters versus number of genomes. Panel A depicts pangenome clusters rising and core genome clusters declining across 1600 genomes (FDA-USDA, NA). Panel B extends to over 3000 genomes (A, plus global).</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F2"><label>Fig 2</label><caption><p><italic toggle="yes">Staphylococcus pseudintermedius</italic> pan-genome statistics. (<bold>A</bold>) FDA-USDA North American data set. (<bold>B</bold>) Global data set inclusive of FDA-USDA.</p></caption><graphic xlink:href="aem.00010-25.f002" position="float"><alt-text>Table presents gene counts across categories for North America and global datasets. Pie charts A and B represent category proportions, with core, soft-core, shell, and cloud segments corresponding to table values.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F3"><label>Fig 3</label><caption><p>Core-genome phylogeny of <italic toggle="yes">Staphylococcus pseudintermedius</italic> isolates from the FDA-USDA North American data set, derived from cat and dog hosts inferred with IQ-TREE v.2.0.3, showing absence of host-specific lineages.</p></caption><graphic xlink:href="aem.00010-25.f003" position="float"><alt-text>Circular phylogenetic tree presents microbial taxa from dog and cat hosts. Branches extend to leaf tips labeled dog or cat, forming host-specific clusters concentrated across distinct radial segments.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F4"><label>Fig 4</label><caption><p>PCA of accessory gene content of <italic toggle="yes">Staphylococcus pseudintermedius</italic> isolates from different sample sets and perspectives. (<bold>A</bold>) Cat and dog FDA-USDA isolates, showing no clear distinction in gene content between hosts. (<bold>B</bold>) FDA-USDA isolates from different geographic regions showing no difference in gene content between areas. (<bold>C</bold>) Global comparative set showing different gene content between several regions, such as North America, E. Asia, and E. Europe. North America: USA, Canada; Oceania: New Zealand, Australia; W Europe: Spain, Netherlands, Germany, France, Italy, Ireland, United Kingdom, Switzerland, Belgium; E Asia: China, South Korea, Hong Kong, Japan; SE Asia: Thailand; E Europe: Slovenia, Hungary, Poland, Russia, Czech Republic; S Asia: Sri Lanka, India; N Europe: Norway, Sweden, Denmark; South America: Argentina, Puerto Rico, Brazil, Grenada; Africa: Botswana; Middle East: Israel, Turkey.</p></caption><graphic xlink:href="aem.00010-25.f004" position="float"><alt-text>Three scatter plots present principal component analyses labeled A, B, and C. Plot A presents dog and cat data clustering by PC1. Plot B presents data grouped by regions within North America. Plot C presents global data grouped by continental regions.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F5"><label>Fig 5</label><caption><p><italic toggle="yes">Staphylococcus pseudintermedius</italic> MLST results. (<bold>A</bold>) North American FDA-USDA set of isolates. (<bold>B</bold>) Global set of isolates. For both sample sets, the number of typable isolates was far less than the total number of isolates because of unique MLST allelic combinations not found on the pubMLST database. See <xref rid="F4" ref-type="fig">Fig. 4</xref> legend for countries included for each region. The map was plotted with the online tool <ext-link xlink:href="https://www.mapchart.net/" ext-link-type="uri">https://www.mapchart.net/</ext-link>.</p></caption><graphic xlink:href="aem.00010-25.f005" position="float"><alt-text>Two regional maps with pie charts present category frequencies. Part A compares five US regions and Canada. Part B presents global regions with pie charts showing category proportions.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F6"><label>Fig 6</label><caption><p>Bayesian analysis of population structure with hierarchical clustering (hierBAPS) of <italic toggle="yes">Staphylococcus pseudintermedius</italic> genome sequence data. (<bold>A</bold>) North American FDA-USDA isolates. (<bold>B</bold>) Global set of isolates. See the <xref rid="F4" ref-type="fig">Fig. 4</xref> legend for countries included for each region.</p></caption><graphic xlink:href="aem.00010-25.f006" position="float"><alt-text>Grouped pie charts present proportions by identifier. Part A compares Canada, Midwest, Northeast, South, and West. Part B compares regions including North America, East Asia, and West Europe.</alt-text></graphic></fig><p>The open pan-genome curve of the global set of 3,685 isolates peaked at 8,061 accessory genes and 1,247 core genes (<xref rid="F1 F2" ref-type="fig">Fig. 1B and 2B</xref>). A core genome alignment of 3,685 global isolates had an alignment size of 1,774,479 bp before curation and 72,161 bp after Gblocks. A PCA of accessory gene content on the global set indicated that there were differences in gene content between several of the regions, including, for example, NA, E. Asia, and E. Europe (<xref rid="F4" ref-type="fig">Fig. 4C</xref>). MLST profiles for the global set indicated that ST71 is the dominant, widely distributed, global sequence type and that ST181 is common in NA but relatively uncommon elsewhere (<xref rid="F5" ref-type="fig">Fig. 5B</xref>). E. Asia has high ST diversity dominated by singletons and STs represented by very few isolates. In the global set, there were an additional 509 isolates without ST assignment on pubMLST and, of these, 474 unique allelic combinations. A total of 16 genetically distinct clusters were identified by hierBAPS at hierarchical cluster level 2, and with <italic toggle="yes">N</italic> &#x0003e; 20 for each cluster (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). Overall, there was evidence for global mixing of isolates, with some indication of genetically distinct clusters comprised of exclusively or indeed mostly NA isolates; however, our sample set is heavily biased toward NA isolates. The majority of E. Asian isolates were found in two separate clusters, suggesting some genetic distinction of samples from that region. Genetic distinction was also apparent between NA, E. Europe, and E. Asia isolates in the principal component analysis of accessory gene content (<xref rid="F4" ref-type="fig">Fig. 4C</xref>).</p></sec><sec id="s3-2"><title>AMR</title><p>AMR laboratory-derived AST phenotype data were available only for the NA set of isolates. Several antibiotics showed little or no evidence for resistance over the 2017&#x02013;2020 period, including rifampin, nitrofurantoin, and vancomycin; others showed an increase up to 2019, followed by a decline in 2020, with a notable exception being amikacin, which showed an increase in resistance between 2019 and 2020 (<xref rid="F7" ref-type="fig">Fig. 7</xref>). A few had little evidence of change over the 4 years such as cefazolin and cephalothin; penicillin showed the highest level of resistance (<xref rid="F7" ref-type="fig">Fig. 7</xref>). There were few notable differences in the proportion of isolates resistant across regions, except Canada, which showed lower levels of resistance for most antibiotics, except for the penicillins (<xref rid="SuF1" ref-type="supplementary-material">Fig. S1</xref>).</p><fig position="float" fig-type="figure" id="F7"><label>Fig 7</label><caption><p>Trends in <italic toggle="yes">Staphylococcus pseudintermedius</italic> lab-tested antibiotic resistance for the period 2017&#x02013;2020. The total number of samples included in each antibiotic trend analysis is indicated under each antibiotic, and standard error bars are marked on each point.</p></caption><graphic xlink:href="aem.00010-25.f007" position="float"><alt-text>Multi-panel line chart presents antibiotic susceptibility trends from 2017 to 2020. Each panel tracks percentage susceptible across years for specific antibiotics, with sample sizes labeled as n.</alt-text></graphic></fig><p>Multidrug resistance was evaluated at both &#x0003e;3 and &#x0003e;5 classes of antibiotics. In NA for laboratory-tested isolates, there were differences between areas, with the most notable difference apparent in the &#x0003e;5 category for the southern USA and 3&#x02013;5 drug classes for Canada, although several other comparisons across regions were also different (<xref rid="F8" ref-type="fig">Fig. 8</xref>). Based on known AMR genes, the percentage of isolates carrying multiple classes of AMR loci showed some minor differences in NA between regions (<xref rid="F9" ref-type="fig">Fig. 9A</xref>), whereas in the global set, large differences were apparent between most regions, with very high proportions of isolates carrying &#x0003e;5 known AMR classes in E. Asia and E. Europe (<xref rid="F9" ref-type="fig">Fig. 9B</xref>). When one considers the percentage of isolates in the global set carrying known AMR genes for different classes of antibiotics, there are notable differences between areas, including, for example, higher proportions in E. Asia, E. Europe, and Oceania for most antibiotics (<xref rid="F10" ref-type="fig">Fig. 10</xref>). Aminoglycoside is one such class of antibiotics with higher proportions of resistance-determining loci compared to W. Europe and N. America. If one considers the contributions of different loci in the separation apparent between E. Asia and NA on the PC2 axis in the principal component analysis of global isolate accessory genomes (<xref rid="F4" ref-type="fig">Fig. 4C</xref>), several of the top 10 loci (based on a ranking of significance) contributing to that separation are involved in conferring aminoglycoside resistance (<xref rid="SuF2" ref-type="supplementary-material">Fig. S2</xref>). Several other mechanisms unique to NA were of note. The trimethoprim resistance gene <italic toggle="yes">dfRS1</italic> and quinolone resistance determinant <italic toggle="yes">grlA</italic>_D84H of DNA topoisomerase IV were unique to NA. Lincosamide resistance gene <italic toggle="yes">lnu(G</italic>) was unique to NA with the exception of one isolate from Kenya. Looking at more recent surveillance data not included in this study, extended spectrum beta-lactamase gene <italic toggle="yes">blaTEM-116</italic> was detected in three 2023 cases from Canada and has thus far not appeared in this species anywhere else in the world.</p><fig position="float" fig-type="figure" id="F8"><label>Fig 8</label><caption><p>Percentage of lab-tested <italic toggle="yes">Staphylococcus pseudintermedius</italic> multidrug-resistant FDA-USDA isolates in different North American regions; 3 to 5 = resistant to three to five different classes of antibiotics; &#x0003e;5 = more than five classes of antibiotics. For category &#x0003e;5 antibiotics: chi-squared = 37.506, df = 4, <italic toggle="yes">P</italic>-value = 1.417e &#x02212; 07 and multiple comparisons: South was significantly different from Canada (<italic toggle="yes">P</italic> = 0.00068) and from Midwest (<italic toggle="yes">P</italic> = 0.00049). Midwest was significantly different from Canada (<italic toggle="yes">P</italic> = 0.03709), and West was significantly different from South (<italic toggle="yes">P</italic> = 0.04095). All other comparisons were non-significant. For category 3&#x02013;5 antibiotics: chi-squared = 7.0415, df = 4, <italic toggle="yes">P</italic>-value = 0.1337 (not significant).</p></caption><graphic xlink:href="aem.00010-25.f008" position="float"><alt-text>Grouped bar chart presents multidrug resistance percentages across five regions. Bars represent resistance to more than five classes and three to five classes of antibiotics by region.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F9"><label>Fig 9</label><caption><p>Percentage of multidrug resistance loci in <italic toggle="yes">Staphylococcus pseudintermedius</italic> genomes. (<bold>A</bold>) North American FDA-USDA isolates. (<bold>B</bold>) Global set of isolates. For NA &#x0003e;5 antibiotics: chi-squared = 20.615, df = 4, <italic toggle="yes">P</italic>-value = 0.0003775 and multiple comparisons: Canada was significantly different from Northeast (<italic toggle="yes">P</italic> = 0.0051) and from South (<italic toggle="yes">P</italic> = 0.0067). For NA 3&#x02013;5 antibiotics: chi-squared = 11.494, df = 4, <italic toggle="yes">P</italic>-value = 0.02154 and multiple comparisons: South was significantly different from Midwest (<italic toggle="yes">P</italic> = 0.042). Statistics are not provided for the global set because many regions had few samples.</p></caption><graphic xlink:href="aem.00010-25.f009" position="float"><alt-text>Grouped bar charts present multidrug resistance percentages across regions. Part A presents five regions and Canada. Part B presents five global regions. Bars represent resistance to more than five and three to five antibiotic classes.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F10"><label>Fig 10</label><caption><p>Percentage of <italic toggle="yes">Staphylococcus pseudintermedius</italic> genomes, from the global set of isolates, with known AMR loci to various antibiotic classes.</p></caption><graphic xlink:href="aem.00010-25.f010" position="float"><alt-text>Grouped bar chart presents percentage of isolates with antimicrobial resistance loci across drug classes for five regions. Aminoglycoside and beta-lactam show highest percentages across all regions.</alt-text></graphic></fig><p>SCCmec is a genomic island that encodes methicillin resistance. SCCmec elements in <italic toggle="yes">S. aureus</italic> are classified into different types based on the combination of variants of mec and the cassette chromosome recombinase gene. This classification scheme was established for <italic toggle="yes">S. aureus</italic> and is the same one used for <italic toggle="yes">S. pseudintermedius</italic> (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B37" ref-type="bibr">37</xref>). Cassette type &#x0201c;mecA&#x0201d; was by far the most dominant type of SCCmec, with its greatest proportional abundance in S. Asia. Some differences in proportional abundance of SCCmec types between areas were apparent, with, for example, E. Europe and SE. Asia dominating in a couple different SCCmec types (<xref rid="SuF3" ref-type="supplementary-material">Fig. S3A</xref>). Differences of SCCmec types between cat, dog, and human hosts were negligible (<xref rid="SuF3" ref-type="supplementary-material">Fig. S3B</xref>).</p></sec><sec id="s3-3"><title>PAN-GWAS&#x02014;Scoary</title><p>The number of genes significantly (<italic toggle="yes">P</italic> &#x0003c; 0.01 for empirical <italic toggle="yes">P</italic>-value and Bonferroni correction) correlated with resistance to the different antibiotics ranged from 22 to 69, with trimethoprim-sulfamethoxazole at the lower end of that range and enrofloxacin at the upper end. We divided the genes correlated with resistance in the Scoary analysis into four categories (<xref rid="F11" ref-type="fig">Fig. 11</xref>). Most genes correlated with resistance are in the category &#x0201c;notAMR + notPlasmid,&#x0201d; which means they are likely on the chromosome and they are not identified as a known AMR mechanism. For some antibiotics, there are very few known AMR genes identified, e.g., some of the cephalosporins, as penicillin-binding protein mutations are often responsible and not identified by AMRFinderPlus. On average, based on the presence and absence of Scoary significant genes, ~89% of phenotypically resistant isolates carried a known AMR locus (<xref rid="SuF7" ref-type="supplementary-material">Table S2</xref>). Several of the antibiotics have a relatively high proportion of the Scoary significant genes identified as on plasmids, but they are not known AMR mechanisms, suggesting these are likely plasmid cargo genes, genes carried with the plasmid, along with a known AMR mechanism. We exclude these from further consideration as possible novel mechanisms since there is no bioinformatic means of separating them from their linkage with the assumed known AMR mechanism carried on the plasmid. PlasmidFinder identified approximately 40% of 1,746 NA genomes as carrying at least one plasmid, and about 46% in the global set of data. Most genomes were assessed as carrying only a single plasmid. Hypothetical genes, those which were annotated as &#x0201c;hypothetical,&#x0201d; comprised the largest group of genes correlated with resistance across all antibiotics, ranging from 44.44 to 80% of the genes for individual antibiotics (<xref rid="SuF8" ref-type="supplementary-material">Table S3</xref>). Not surprisingly, the top 10 genes correlated with resistance (ranking based on level of significance) for each antibiotic included at least a few hypotheticals and, frequently, the majority. Often, these were likely plasmid cargo genes, for example, in the case of tetracyclines (tetracycline, doxycycline, minocycline) where the resistance mechanism carried on the plasmid was <italic toggle="yes">tetM</italic>. On other occasions, the same hypothetical, which was judged not to be on a plasmid and therefore likely chromosomal, appeared across several antibiotics in the same class, suggesting something of note for possible further experimental evaluation. An example would be hypothetical protein Panaroo group_957, which was the top-ranked Scoary significant gene for fluoroquinolones. Examples of functionally annotated genes that appeared in the top 10 most abundant Scoary significant loci (based solely on gene presence/absence) across antibiotics tested, and which were not known resistant genes, included glycerophosphodiester phosphodiesterase (ugpQ_2), ubiquinone biosynthesis O-methyltransferase (COQ3), and <italic toggle="yes">Hin</italic> DNA invertase. As expected, <italic toggle="yes">mecA</italic> was identified to be associated with all beta-lactams in this study. A complete list of genes significantly correlated with resistance is available in <xref rid="SuF8" ref-type="supplementary-material">Table S3</xref>.</p><fig position="float" fig-type="figure" id="F11"><label>Fig 11</label><caption><p>Pan-GWAS (Scoary) results for tested antibiotics. The numbers above the pie diagrams are the numbers of genes judged to be significantly correlated with resistance for that antibiotic, and their proportions are broken down into the four indicated components in these pie diagrams. AMR + plasmid = known AMR locus carried on a plasmid; plasmid + not AMR = gene carried on a plasmid that is not a known AMR locus; AMR + not plasmid = known AMR locus on the chromosome; not_AMR + not_plasmid = not a known AMR locus carried on the chromosome.</p></caption><graphic xlink:href="aem.00010-25.f011" position="float"><alt-text>Pie charts present plasmid and antimicrobial resistance locus combinations across antibiotics in North America. Most segments belong to not AMR not plasmid, with few antibiotics depicting other combinations.</alt-text></graphic></fig></sec></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><sec id="s4-1"><title>Population genetics and genomics</title><p>This manuscript presents an analysis of the largest <italic toggle="yes">S. pseudintermedius</italic> genomic data set yet assembled, concomitant with AMR data of 23 antibiotics (19 with sufficient data for pan-GWAS) from over 1,700 dog isolates from NA, and a pan-GWAS analysis of these different antibiotics across these genomes. Along with the dog genomes from NA, 176 cats were also completed. Although this number was far less than the canine sample set, it was sufficient to indicate that there was no separate adaptive lineage of cats relative to dogs. This was apparent at both the level of a core-genome phylogeny of dog and cat isolates as well as PCA of their gene content. Similar findings have recently been reported involving human isolates, where genome architecture was indistinguishable between dogs and human hosts (<xref rid="B1" ref-type="bibr">1</xref>). These authors did, however, find some genetic distinction in niche-specific (diagnostic versus colonizing) genes involved in defense. We suggest that future molecular evolution analyses could possibly identify site-specific genetic features of molecular adaptation between cats and dogs in immune evasion genes shared between each host.</p><p>Our MLST analysis on this large set of <italic toggle="yes">S. pseudintermedius</italic> genomes provided evidence for clonal expansion of certain dominant sequence types in NA that had both similarities and differences to that on a global scale. ST181 was the dominant sequence type throughout the USA but not so in Canada where ST71 was dominant. ST181 is an MRSP multidrug-resistant clone that appears to have replaced other sequence types such as ST71 (also MRSP) as the dominant clone in the USA over the course of the last decade (<xref rid="B38" ref-type="bibr">38</xref>). In a recent study, Bruce et al. (<xref rid="B8" ref-type="bibr">8</xref>) found that of 170 <italic toggle="yes">S</italic>. <italic toggle="yes">pseudintermedius</italic> isolates, ST71 was absent from New England, although present in a few other states. Nevertheless, over the 2017&#x02013;2020 period of our present collection, ST71 remains a prevalent clone in the western USA and in Canada. Two other STs well represented in the NA set are STs 551 and 155. ST551 is an MRSP clone that has recently been reported as a commensal in dog skin (<xref rid="B39" ref-type="bibr">39</xref>), suggesting this highly drug-resistant clone could be an important one to watch for in zoonotic infections. ST155 is an MRSP clone that has been reported in human infections, as have ST45, ST241, ST1337, ST1412, ST673, ST686, ST181, ST158, and ST233 (<xref rid="B6" ref-type="bibr">6</xref>), several of which were identified in our NA set (<xref rid="F5" ref-type="fig">Fig. 5A</xref>).</p><p>In the global set of data, ST71 was the dominant clone, with ST181 only common in NA. ST71 is reported as the most prevalent clone in other analyses of European <italic toggle="yes">S. pseudintermedius</italic>, although its dominance is suggested to be declining over the course of the last decade (<xref rid="B40" ref-type="bibr">40</xref><xref rid="B41" ref-type="bibr">&#x02013;</xref><xref rid="B43" ref-type="bibr">43</xref>), and gradually being replaced by ST258 (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B44" ref-type="bibr">44</xref>), at least in western Europe. ST258 is reported to be more susceptible to licensed veterinary antimicrobials, including fluoroquinolones (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B45" ref-type="bibr">45</xref>). We found ST258 to be rare in NA. Our analysis divided the European data into western and eastern regions, and although the sample size for E. Europe was much less, there were several differences apparent between the two regions. E. Europe had a much higher proportion of the isolates represented by ST71 and ST551, and much lower overall ST diversity than Western Europe. The last two regions in our global ST categorization&#x02014;Oceania and E. Asia&#x02014;had their own unique ST profiles. Oceania showed a distinct dominance of ST496, which was rare elsewhere in the world. Earlier reports on <italic toggle="yes">S. pseudintermedius</italic> from Australia reported the first occurrence of this multidrug-resistant clone ST496 and suggested that it may have evolved on that continent, possibly in New South Wales (<xref rid="B37" ref-type="bibr">37</xref>). Our analysis suggests that it is no longer exclusively found in Australia&#x02014;we detected it in NA and Western Europe, albeit in low numbers. At the time of Worthing et al.&#x02019;s (<xref rid="B37" ref-type="bibr">37</xref>) study, ST71 was the dominant ST, but our results suggest that, like other parts of the world, ST71 dominance in Australia appears to be waning and, in this case, being replaced by ST496. E. Asia differed from other regions of our global sample set in having the highest ST diversity, with the vast majority of the sampled STs (<italic toggle="yes">N</italic> = 181) being represented by less than five isolates. Although accurate comparisons across studies can be hampered because of large differences in sample sizes, it nonetheless does appear that clonal structure of <italic toggle="yes">S. pseudintermedius</italic> is in flux, possibly related to lateral acquisition of SCCmec cassettes or other resistance-determining loci that then allow certain clones to gain dominance.</p><p>The hierBAPS population genomics analyses provide a different perspective on genetic differences across regions, this time based on curated core genome alignments, rather than just fragments of seven housekeeping genes. Our study provides, for the first time, adequate sample numbers across NA to provide any attempt at evaluating whether there might be genetically distinct pockets of <italic toggle="yes">S. pseudintermedius</italic> in the USA and Canada. In NA, the clear result was that there is no support for population genetic geographic clustering; the genetically distinct clusters identified by hierBAPS comprised multi-geographic regions. In the global data set, the hierBAPS population genomics did identify several genetic clusters that were either exclusively NA or very nearly; the remaining genetic clusters were mixed in regional composition. The distinction apparent in NA compared to much of the rest of the world is undoubtedly impacted by the much larger sample size for NA, which could conceivably result in additional genetically distinct clusters. However, some of these NA clusters are nonetheless substantial in the numbers represented, often over 100 isolates.</p><p>When considering the accessory genome content, differences were observed between geographic areas in the global data set, including a tendency toward unique content in regions such as E. Europe, NA, and E. Asia, and to a lesser extent, Oceania and South America. Some of this difference in gene content is at least partly a consequence of differences in the content of AMR loci, which our results support when this is broken down into genes conferring resistance to different classes of antibiotics across regions (<xref rid="F11" ref-type="fig">Fig. 11</xref>). These differences in turn may reflect differences in antibiotic prescribing and usage habits across different countries. Recent analysis of this topic for human pathogens, including <italic toggle="yes">S. aureus</italic>, has developed indices that consider levels of resistance, as well as their association with antibiotic consumption (<xref rid="B46" ref-type="bibr">46</xref>). Evaluations with such indices in mind have concluded that higher levels of resistance in E. Asia, as well as in some E. European countries, may be a consequence of inappropriate antibiotic consumption (<xref rid="B46" ref-type="bibr">46</xref>), including the use of antibiotics to treat conditions not related to a bacterial infection, the use of the wrong antibiotic, the wrong dosage, or the wrong duration. Similar detailed global comparisons of AMR in companion animal medicine are not available due to various factors, including limitations on the number of dilution steps available on commercial diagnostic panels that preclude obtaining accurate MIC or data. The majority of drugs in our analysis contain four or fewer dilutions and are therefore subject to the same limitations. However, if one assumes that poor antibiotic stewardship in human medicine of some countries would also be true in animal medicine of those same countries, then this might explain the higher levels of known AMR mechanisms in <italic toggle="yes">S. pseudintermedius</italic> in E. Asia and E. Europe. AMR comparisons, especially those that may contain unbiasedly sampled sequences (sequences targeted specifically because of resistance or some other highlighted phenotype), may then influence downstream analyses, and thus should be considered as a possible limitation for this study. Furthermore, <italic toggle="yes">S. aureus</italic> does infect dogs and cats (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>), and human to dog transmission of <italic toggle="yes">S. aureus</italic> has also been documented (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>). Both E. Europe and E. Asia are regions with high incidence of methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA) (<xref rid="B51" ref-type="bibr">51</xref><xref rid="B52" ref-type="bibr">&#x02013;</xref><xref rid="B53" ref-type="bibr">53</xref>). Thus, human to dog transmission of <italic toggle="yes">S. aureus</italic> may occur with subsequent lateral gene transfer of AMR loci between <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">S. pseudintermedius</italic> as a possible outcome, particularly since they are closely related organisms and share many of the same SCCmec cassettes and plasmids.</p></sec><sec id="s4-2"><title>Pan-GWAS</title><p>Our pan-GWAS analysis performed with Scoary identified a number of loci correlated with resistance that were judged to be chromosomal and were not known AMR loci. The number of genes significantly correlated with resistance to each of the tested antibiotics ranged from 22 to 69 (<xref rid="F11" ref-type="fig">Fig. 11</xref>), and for each antibiotic, hypothetical proteins dominated the list (<xref rid="SuF8" ref-type="supplementary-material">Table S3</xref>). In several instances, the same chromosomal hypothetical protein was found to be correlated with resistance to multiple antibiotics, suggesting reason for further laboratory experimental evaluation regarding these loci. Similarly, numerous chromosomal annotated genes that were not known AMR mechanisms were correlated with resistance to multiple classes of antibiotics. Examples of this included the CRISPR-associated endoribonuclease proteins Cas1, Cas2, Cas6, Csm3, and Csm4. CRISPR-Cas systems provide the bacteria adaptive immune protection against foreign mobile genetic elements. Various articles have focused on the CRISPR-Cas system as a means of limiting AMR development by restricting the acquisition of mobile elements, including those which carry resistance cassettes, and the possible use of this system to treat AMR pathogens (<xref rid="B54" ref-type="bibr">54</xref><xref rid="B55" ref-type="bibr">&#x02013;</xref><xref rid="B56" ref-type="bibr">56</xref>). Our results, on the other hand, suggest a role for CRISPR-Cas systems in promoting antibiotic resistance. An earlier study on <italic toggle="yes">Francisella novicida</italic> provided experimental evidence that, in this species, the CRISPR-Cas system was promoting AMR and indicated that this involved enhancing envelope integrity through the regulation of a bacterial lipoprotein (<xref rid="B57" ref-type="bibr">57</xref>). We are not aware of the CRISPR-Cas system reported as a potential AMR mechanism in <italic toggle="yes">Staphylococcus,</italic> and we suggest this deserves consideration in not only <italic toggle="yes">S. pseudintermedius</italic> but possibly also <italic toggle="yes">S. aureus</italic>.</p><p>Other Scoary significant genes were not putative multidrug resistance mechanisms but instead were correlated with a single class of antibiotics. Several genes from the sbo-alb operon, responsible for the biosynthesis of subtilosin A, a bacteriocin produced by <italic toggle="yes">Bacillus subtilis</italic> (<xref rid="B58" ref-type="bibr">58</xref>), were correlated with macrolide resistance in our analysis. The genes from this operon correlated with macrolide resistance were <italic toggle="yes">sboA</italic>, <italic toggle="yes">albA</italic>, <italic toggle="yes">albB</italic>, and <italic toggle="yes">albC. sboA</italic> is responsible for subtilosin A production. AlbA catalyzes thioether bond formation in subtilosin A (<xref rid="B59" ref-type="bibr">59</xref>). AlbB is a small hydrophobic peptide involved in subtilosin immunity (<xref rid="B60" ref-type="bibr">60</xref>). AlbC is an ABC transporter thought to be involved in export of subtilosin A (<xref rid="B60" ref-type="bibr">60</xref>). SboA has been shown to have antimicrobial activity against a wide range of gram-positive and gram-negative bacteria (<xref rid="B61" ref-type="bibr">61</xref>). The protein products of <italic toggle="yes">albB</italic>, <italic toggle="yes">albC</italic>, and <italic toggle="yes">albD</italic> function in subtilosin immunity (<xref rid="B60" ref-type="bibr">60</xref>) which is necessary because a bacteriocin-producing bacterium needs to be immune to the bacteriocin it produces. We found the sbo-alb operon to be widely distributed among <italic toggle="yes">S. pseudintermedius</italic> isolates from our cats (<xref rid="B19" ref-type="bibr">19</xref>) and dogs (546; see <xref rid="SuF4" ref-type="supplementary-material">Fig. S4</xref> for the diagram of the <italic toggle="yes">S. pseudintermedius</italic> operon). An intact operon in <italic toggle="yes">S. pseudintermedius</italic> appears to consist of <italic toggle="yes">sboA, albA, albB, albC, albD</italic>, and <italic toggle="yes">albE</italic>; however, we do not have transcriptome data to verify its functional transcription. A complete operon in <italic toggle="yes">Bacillus subtilis</italic> consists of these same loci, with the addition of a small <italic toggle="yes">sboX</italic> locus between <italic toggle="yes">sboA</italic> and <italic toggle="yes">albA</italic> (<italic toggle="yes">sboX</italic> in <italic toggle="yes">B. subtilis</italic> is a very short peptide with an overlapping reading frame with <italic toggle="yes">sboA</italic>, and based on our homology comparisons, it is not clear whether <italic toggle="yes">S. pseudintermedius</italic> carries this locus) as well as <italic toggle="yes">albF</italic> and <italic toggle="yes">albG</italic> (<xref rid="B58" ref-type="bibr">58</xref>). BLAST searches of NCBI identified homologs from <italic toggle="yes">Staphylococcus felis</italic> (within which it appeared to be relatively common), <italic toggle="yes">Staphylococcus epidermidis</italic> (again relatively common), and a few representative isolates of several other species of <italic toggle="yes">Staphylococcus</italic> including <italic toggle="yes">capitis, agnetis, caprae, delphini</italic>, but completely lacking from <italic toggle="yes">S. aureus</italic>. A recent study has shown that topical applications of bacteriocins from <italic toggle="yes">B. subtilis</italic> can result in decolonization of skin infections by <italic toggle="yes">S. aureus</italic> (<xref rid="B62" ref-type="bibr">62</xref>). Subtilosin A can inhibit biofilm formation in clinical <italic toggle="yes">S. aureus</italic> strains (<xref rid="B63" ref-type="bibr">63</xref>) and <italic toggle="yes">Bacillus subtilis</italic> lipopeptides derived from cell-free extract disrupt quorum sensing and biofilm assembly in <italic toggle="yes">S. aur</italic>eus (<xref rid="B64" ref-type="bibr">64</xref>). Thus, the absence of this locus in <italic toggle="yes">S. aureus</italic> is likely because the species does not have the ability to withstand the production of this bacteriocin. <italic toggle="yes">S. epidermidis,</italic> on the other hand, does appear to carry this operon and is a closely related species to <italic toggle="yes">S. aureus</italic> (<xref rid="B65" ref-type="bibr">65</xref>). Given the distribution of this operon across numerous <italic toggle="yes">Staphylococcus</italic> species and, in particular, those closely related to <italic toggle="yes">S. aureus</italic>, such as the Epidermidis species group (<xref rid="B65" ref-type="bibr">65</xref>), the most parsimonious hypothesis is that this locus was present in at least the ancestor of the Epidermidis/Aureus and Hyicus/Intermedius cluster groups, and possibly deeper in the radiation of <italic toggle="yes">Stapylococcus</italic> species, and was then lost in <italic toggle="yes">S. aureus</italic>. Subtilosin A is an example of a radical SAM enzyme (S-adenosylmethionine) that can catalyze sulfur-to-alpha carbon thioether cross-linked peptides (referred to as sactipeptides), which is a sub-class of ribosomally synthesized and post-translationally modified (in this case by AlbA) peptides (RiPPs) (<xref rid="B66" ref-type="bibr">66</xref>). Sactipeptides are RiPPs that have various biological properties such as antibacterial, spermicidal, and hemolytic. Macrolide resistance is often conferred by modification, most commonly methylation, of the ribosomal target. Some radical SAM proteins catalyze unusual methylations including of rRNA ([<xref rid="B67" ref-type="bibr">67</xref>]; although not subtilosin to our knowledge). Possibly, the macrolide resistance we see in these <italic toggle="yes">sboA</italic>-carrying isolates is related to an rRNA modification inherited with the <italic toggle="yes">sboA</italic> operon that facilitates the production of the subtilosin ribosomal peptide, as well as macrolide resistance. Whatever the possible link between macrolide resistance and subtilosin A in <italic toggle="yes">S. pseudintermedius,</italic> the growing interest in using this bacteriocin as an agent to fight <italic toggle="yes">S. au</italic>r<italic toggle="yes">eus</italic> infections, particularly those resistant to multiple antibiotics, warrants further investigation in <italic toggle="yes">S. pseudintermedius</italic>, a closely related species to <italic toggle="yes">S. au</italic>reus, possibly making the <italic toggle="yes">S. pseudintermedius</italic> peptide a useful agent in such endeavors.</p><p>Numerous other putative resistance loci of note were identified in our pan-GWAS analysis. Several different recombinases were correlated with resistance<italic toggle="yes">&#x02014;xerC, hin</italic>, and <italic toggle="yes">pinR</italic>. Certain antibiotics result in double-strand DNA breaks in bacterial chromosomes, which need to be repaired (the SOS response). <italic toggle="yes">xerC</italic> has recently been established as one of the genes in the <italic toggle="yes">S. aureus</italic> SOS response, and deletion of this gene increased the susceptibility of <italic toggle="yes">S. aureus</italic> to various classes of antibiotics (<xref rid="B68" ref-type="bibr">68</xref>). DNA invertase <italic toggle="yes">hin</italic> is a member of the hin family of site-specific recombinases, and in our analysis was correlated with resistance to 11 different antibiotics. <italic toggle="yes">pinR</italic> is a serine recombinase that facilitates the process of genetic material exchange between organisms through DNA recombination (<xref rid="B69" ref-type="bibr">69</xref>). Antibiotics, such as quinolones, aminoglycosides, and &#x003b2;-lactams, are known to induce oxidative stress and redox alterations that contribute to bacteria cellular damage and death (<xref rid="B70" ref-type="bibr">70</xref>). Several of the genes from the myo-inositol (<italic toggle="yes">iol</italic>) operon were correlated with resistance in our analysis&#x02014;this operon is involved in protecting the bacteria from oxidative stress (<xref rid="B71" ref-type="bibr">71</xref>). There were a few examples of genes that are known resistance mechanisms for a certain class of antibiotics but were correlated in our analysis with resistance for different classes of antibiotics. For these specific antibiotics, we consider them as not a known resistance mechanism (i.e. not listed as such on AMRFinderPlus). An example of this is streptothricin acetyltransferase A, correlated in our analysis with resistance to six antibiotics from different classes. Another example is two aminoglycoside resistance mechanisms&#x02014;aminoglycoside 3&#x000b4;-phosphotransferase, <italic toggle="yes">aphA,</italic> and aminoglycoside 6-adenylyltransferase, <italic toggle="yes">aadK</italic>, correlated with multiple classes of non-aminoglycoside antibiotics in our Scoary results.</p><p>Methicillin-resistant <italic toggle="yes">S. pseudintermedius</italic> and <italic toggle="yes">S. aureus</italic> are a major health concern for a number of reasons, including, for example, (i) these strains are resistant to methicillin (oxacillin), an antibiotic that is active against many penicillinase-producing strains of <italic toggle="yes">Staphylococcus</italic> that are resistant to other penicillins; (ii) they generally also carry resistance loci to a range of other classes of antibiotics; (iii) they are widely distributed, including increasing prevalence in hospitals; and (iv) the principal molecular agent of resistance&#x02014;the <italic toggle="yes">mecA</italic> gene&#x02014;is carried on a lateral gene transmissible (LGT) SCCmec cassette. Methicillin is no longer commercially available in the USA, and oxacillin has replaced it because it maintains better activity during storage and is better at detecting heteroresistant strains. The acronym MRSA is nonetheless still used to describe these isolates because of the historic role of methicillin. In our NA collection of <italic toggle="yes">S. pseudintermedius</italic>, <italic toggle="yes">mecA</italic> was found in 89% of the isolates judged to be oxacillin resistant and only 3.3% of the oxacillin-sensitive isolates carried <italic toggle="yes">mecA</italic>. Our results suggest, and it does remain an open question as to whether, there might be additional loci (<xref rid="B72" ref-type="bibr">72</xref><xref rid="B73" ref-type="bibr">&#x02013;</xref><xref rid="B74" ref-type="bibr">74</xref>) that could be contributing to oxacillin resistance. In our analysis, the vast majority of Scoary significant genes for oxacillin were hypotheticals. The few annotated putative chromosomal genes (i.e., other than <italic toggle="yes">mecA</italic>) that were correlated with resistance included glycerophosphodiester phosphodiesterase cytoplasmic (<italic toggle="yes">ugpQ</italic>), hydroxymethylglutaryl-CoA synthase (<italic toggle="yes">mvaS</italic>), maltose O-acetyltransferase (<italic toggle="yes">maa</italic>), HTH-type transcriptional repressor (<italic toggle="yes">glcR</italic>), Na(+) Li(+) K(+)/H(+) antiporter (<italic toggle="yes">mdrP</italic>), DNA invertase (<italic toggle="yes">hin</italic>), HTH-type transcriptional regulator (<italic toggle="yes">pchR</italic>), beta-lactamase (<italic toggle="yes">blaZ</italic>), and protein adenylyltransferase (<italic toggle="yes">soFic</italic>). This latter gene (<italic toggle="yes">soFic</italic>) is a member of the Fic family of proteins which can induce the SOS response (<xref rid="B75" ref-type="bibr">75</xref>), for controlling DNA damage, one consequence of antibiotics, to which bacteria need to respond. It remains plausible that other contributors and not just the <italic toggle="yes">mecA</italic> gene are playing a role in oxacillin resistance; perhaps some of the loci on our oxacillin resistance list (<xref rid="SuF8" ref-type="supplementary-material">Table S3</xref>) warrant some laboratory scrutiny in this regard. Similar to oxacillin resistance, other antibiotics in our analysis had approximately 10% of tested isolates that were resistant but did not carry a known AMR gene, further suggesting the possibility of unknown AMR loci for antibiotics more broadly (see <xref rid="SuF7" ref-type="supplementary-material">Table S2</xref>).</p><p>There are a wide range of interesting potential antimicrobial loci identified in our analysis, but these are all correlations and would need experimental evaluation for cause-effect relationships to AMR. Furthermore, genotypic correlations to phenotypes may change as the AST interpretations are updated or if infections are transmitted to other hosts or body sites. Our purpose here was to provide a short list of candidate genes for the community of interested scientists to evaluate as they see fit. It is our hope this can be useful and could lend insight on control of AMR in not only <italic toggle="yes">S. pseudintermedius</italic> but possibly also in <italic toggle="yes">S. aureus</italic>.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>Trevor L. Alexander, Melanie Prarat, Ashley Johnson, Katherine Shiplett, Dominika Jurkovic, and Jing Cui provided excellent technical support.</p><p>This work was supported by (FOA PAR-18-604) and performed in collaboration with the US Food and Drug Administration&#x02019;s Veterinary Laboratory Investigation and Response Network under grants 1U18FD006993 and 5U18FD006716 to Cornell, 1U18FD006442 to Louisiana State, 1U18FD006712 to Ohio ADDL, 1U18FD006862 and 1U18FD007244 to University of Guelph, 1U18FD006558 to South Dakota, and 1U18FD006453 to Washington State. USDA funding for bacterial genomic capacity building was provided under Farm Bill award AP20VSD&#x00026;B000C018.</p><p>The views expressed in this article are those of the authors and do not necessarily reflect the official policy of the Department of Health and Human Services, the US Food and Drug Administration, or the US Government. Reference to any commercial materials, equipment, or process does not in any way constitute approval, endorsement, or recommendation by the Food and Drug Administration.</p></ack><sec sec-type="data-availability" id="s5-1"><title>DATA AVAILABILITY</title><p>This study utilized genome sequences that were publicly available in NCBI. Genome sequences, metadata, and susceptibility phenotypes for the dog and cat isolates generated by the FDA and USDA monitoring programs are available in NCBI BioProjects <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA314609" ext-link-type="uri">PRJNA314609</ext-link> and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA510565/" ext-link-type="uri">PRJNA510565</ext-link>. An aggregate version of the phenotypic and genotypic data for the dog isolates can be viewed via an interactive Tableau report at the following link: <ext-link xlink:href="https://www.fda.gov/animal-veterinary/national-antimicrobial-resistance-monitoring-system/2021-animal-pathogen-amr-data" ext-link-type="uri">https://www.fda.gov/animal-veterinary/national-antimicrobial-resistance-monitoring-system/2021-animal-pathogen-amr-data</ext-link>.</p></sec><sec sec-type="supplementary-material" id="s5-2"><title>SUPPLEMENTAL MATERIAL</title><p specific-use="print-only">The following material is available online at <ext-link xlink:href="https://doi.org/10.1128/aem.00010-25" ext-link-type="uri">https://doi.org/10.1128/aem.00010-25</ext-link>.</p><supplementary-material id="SuF1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF1</object-id><label>Fig. S1</label><caption><title>aem.00010-25-s0001.pdf</title><p>Percentage of lab tested isolates resistant to various antibiotics across the geographic regions of North America.</p></caption><media xlink:href="aem.00010-25-s0001.pdf"/></supplementary-material><supplementary-material id="SuF2" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF2</object-id><label>Fig. S2</label><caption><title>aem.00010-25-s0002.pdf</title><p>Genes that were the greatest contributors to separation of the PC2 axis in the principal component analysis of accessory gene content.</p></caption><media xlink:href="aem.00010-25-s0002.pdf"/></supplementary-material><supplementary-material id="SuF3" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF3</object-id><label>Fig. S3</label><caption><title>aem.00010-25-s0003.pdf</title><p>Distribution of SCCmec types.</p></caption><media xlink:href="aem.00010-25-s0003.pdf"/></supplementary-material><supplementary-material id="SuF4" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF4</object-id><label>Fig. S4</label><caption><title>aem.00010-25-s0004.pdf</title><p>sbo-alb operon.</p></caption><media xlink:href="aem.00010-25-s0004.pdf"/></supplementary-material><supplementary-material id="SuF5" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF5</object-id><label>Supplemental legends</label><caption><title>aem.00010-25-s0005.docx</title><p>Legends for all supplemental material.</p></caption><media xlink:href="aem.00010-25-s0005.docx"/></supplementary-material><supplementary-material id="SuF6" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF6</object-id><label>Table S1</label><caption><title>aem.00010-25-s0006.xlsx</title><p>Number of isolates represented for each country used in this study.</p></caption><media xlink:href="aem.00010-25-s0006.xlsx"/></supplementary-material><supplementary-material id="SuF7" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF7</object-id><label>Table S2</label><caption><title>aem.00010-25-s0007.xlsx</title><p>Percentages of phenotypically resistant isolates containing a known AMR gene that is also Scoary significant by total number of phenotypically resistant isolates for each antibiotic tested.</p></caption><media xlink:href="aem.00010-25-s0007.xlsx"/></supplementary-material><supplementary-material id="SuF8" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.00010-25.SuF8</object-id><label>Table S3</label><caption><title>aem.00010-25-s0008.xlsx</title><p>Scoary significant genes for each antibiotic tested.</p></caption><media xlink:href="aem.00010-25-s0008.xlsx"/></supplementary-material><p specific-use="online-only">ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse. </p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sawhney</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Vargas</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Wallace</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Muenks</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Lubbers</surname>
<given-names>BV</given-names></string-name>, <string-name><surname>Fritz</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Burnham</surname>
<given-names>C-A</given-names></string-name>, <string-name><surname>Dantas</surname>
<given-names>G</given-names></string-name></person-group>. <year>2023</year>. <article-title>Diagnostic and commensal Staphylococcus pseudintermedius genomes reveal niche adaptation through parallel selection of defense mechanisms</article-title>. <source>Nat Commun</source>
<volume>14</volume>:<elocation-id>7065</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41467-023-42694-5</pub-id><pub-id pub-id-type="pmid">37923729</pub-id>
</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bierowiec</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Miszczak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Korzeniowska-Kowal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wzorek</surname>
<given-names>A</given-names></string-name>, <string-name><surname>P&#x00142;&#x000f3;karz</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Gamian</surname>
<given-names>A</given-names></string-name></person-group>. <year>2021</year>. <article-title>Epidemiology of Staphylococcus pseudintermedius in cats in Poland</article-title>. <source>Sci Rep</source>
<volume>11</volume>:<elocation-id>18898</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41598-021-97976-z</pub-id><pub-id pub-id-type="pmid">34556720</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>De Martino</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lucido</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mallardo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Facello</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mallardo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Iovane</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Pagnini</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Tufano</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Catalanotti</surname>
<given-names>P</given-names></string-name></person-group>. <year>2010</year>. <article-title>Methicillin-resistant staphylococci isolated from healthy horses and horse personnel in Italy</article-title>. <source>J Vet Diagn Invest</source>
<volume>22</volume>:<fpage>77</fpage>&#x02013;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1177/104063871002200114</pub-id><pub-id pub-id-type="pmid">20093688</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hanselman</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Kruth</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Rousseau</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name></person-group>. <year>2009</year>. <article-title>Coagulase positive staphylococcal colonization of humans and their household pets</article-title>. <source>Can Vet J</source>
<volume>50</volume>:<fpage>954</fpage>&#x02013;<lpage>958</lpage>.<pub-id pub-id-type="pmid">19949556</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Carroll</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Burnham</surname>
<given-names>C-A</given-names></string-name>, <string-name><surname>Westblade</surname>
<given-names>LF</given-names></string-name></person-group>. <year>2021</year>. <article-title>From canines to humans: clinical importance of Staphylococcus pseudintermedius</article-title>. <source>PLoS Pathog</source>
<volume>17</volume>:<elocation-id>e1009961</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1009961</pub-id><pub-id pub-id-type="pmid">34855921</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Moses</surname>
<given-names>IB</given-names></string-name>, <string-name><surname>Santos</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Gales</surname>
<given-names>AC</given-names></string-name></person-group>. <year>2023</year>. <article-title>Human colonization and infection by Staphylococcus pseudintermedius: an emerging and underestimated zoonotic pathogen</article-title>. <source>Microorganisms</source>
<volume>11</volume>:<elocation-id>581</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms11030581</pub-id><pub-id pub-id-type="pmid">36985155</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Calabro</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Sadhu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Aprea</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guarino</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cazer</surname>
<given-names>CL</given-names></string-name></person-group>. <year>2024</year>. <article-title>Longitudinal antimicrobial susceptibility trends of canine Staphylococcus pseudintermedius</article-title>. <source>Prev Vet Med</source>
<volume>226</volume>:<fpage>106170</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prevetmed.2024.106170</pub-id><pub-id pub-id-type="pmid">38493570</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bruce</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Mydosh</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Ball</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Needle</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Gibson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Andam</surname>
<given-names>CP</given-names></string-name></person-group>. <year>2022</year>. <article-title>Accessory genome dynamics of local and global Staphylococcus pseudintermedius populations</article-title>. <source>Front Microbiol</source>
<volume>13</volume>:<elocation-id>798175</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2022.798175</pub-id><pub-id pub-id-type="pmid">35222331</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lynch</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Helbig</surname>
<given-names>KJ</given-names></string-name></person-group>. <year>2021</year>. <article-title>The complex diseases of Staphylococcus pseudintermedius in canines: where to next?</article-title>
<source>Vet Sci</source>
<volume>8</volume>:<elocation-id>11</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/vetsci8010011</pub-id><pub-id pub-id-type="pmid">33477504</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Alcock</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Huynh</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Chalil</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Raphenya</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Wlodarski</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Edalatmand</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Petkau</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Syed</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Tsang</surname>
<given-names>KK</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2023</year>. <article-title>CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database</article-title>. <source>Nucleic Acids Res</source>
<volume>51</volume>:<fpage>D690</fpage>&#x02013;<lpage>D699</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkac920</pub-id><pub-id pub-id-type="pmid">36263822</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Feldgarden</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Brover</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Fedorov</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Haft</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Prasad</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Klimke</surname>
<given-names>W</given-names></string-name></person-group>. <year>2022</year>. <article-title>Curation of the AMRFinderPlus databases: applications, functionality and impact</article-title>. <source>Microb Genom</source>
<volume>8</volume>:<elocation-id>mgen000832</elocation-id>. doi:<pub-id pub-id-type="doi">10.1099/mgen.0.000832</pub-id><pub-id pub-id-type="pmid">35675101</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Pantosti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sanchini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Monaco</surname>
<given-names>M</given-names></string-name></person-group>. <year>2007</year>. <article-title>Mechanisms of antibiotic resistance in Staphylococcus aureus</article-title>. <source>Future Microbiol</source>
<volume>2</volume>:<fpage>323</fpage>&#x02013;<lpage>334</lpage>. doi:<pub-id pub-id-type="doi">10.2217/17460913.2.3.323</pub-id><pub-id pub-id-type="pmid">17661706</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lef&#x000e9;bure</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Stanhope</surname>
<given-names>MJ</given-names></string-name></person-group>. <year>2007</year>. <article-title>Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition</article-title>. <source>Genome Biol</source>
<volume>8</volume>:<elocation-id>R71</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/gb-2007-8-5-r71</pub-id><pub-id pub-id-type="pmid">17475002</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Tettelin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Masignani</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Cieslewicz</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Donati</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Medini</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>NL</given-names></string-name>, <string-name><surname>Angiuoli</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Crabtree</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Durkin</surname>
<given-names>AS</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2005</year>. <article-title>Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial &#x0201c;pan-genome&#x0201d;</article-title> . <source>Proc Natl Acad Sci USA</source>
<volume>102</volume>:<fpage>13950</fpage>&#x02013;<lpage>13955</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0506758102</pub-id><pub-id pub-id-type="pmid">16172379</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Brynildsrud</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Bohlin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Scheffer</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Eldholm</surname>
<given-names>V</given-names></string-name></person-group>. <year>2016</year>. <article-title>Rapid scoring of genes in microbial pan-genome-wide association studies with Scoary</article-title>. <source>Genome Biol</source>
<volume>17</volume>:<fpage>238</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-016-1108-8</pub-id><pub-id pub-id-type="pmid">27887642</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>John</surname>
<given-names>J</given-names></string-name>, <string-name><surname>George</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nori</surname>
<given-names>SRC</given-names></string-name>, <string-name><surname>Nelson-Sathi</surname>
<given-names>S</given-names></string-name></person-group>. <year>2019</year>. <article-title>Phylogenomic analysis reveals the evolutionary route of resistant genes in Staphylococcus aureus</article-title>. <source>Genome Biol Evol</source>
<volume>11</volume>:<fpage>2917</fpage>&#x02013;<lpage>2926</lpage>. doi:<pub-id pub-id-type="doi">10.1093/gbe/evz213</pub-id><pub-id pub-id-type="pmid">31589296</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC)</collab></person-group>. <year>2009</year>. <article-title>Classification of staphylococcal cassette chromosome mec (SCC mec): guidelines for reporting novel SCC mec elements</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>53</volume>:<fpage>4961</fpage>&#x02013;<lpage>4967</lpage>. doi:<pub-id pub-id-type="doi">10.1128/aac.00579-09</pub-id><pub-id pub-id-type="pmid">19721075</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Wegener</surname>
<given-names>Alice</given-names></string-name>, <string-name><surname>Damborg</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Guardabassi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Moodley</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mughini-Gras</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Duim</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wagenaar</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Broens</surname>
<given-names>EM</given-names></string-name></person-group>. <year>2020</year>. <article-title>Specific staphylococcal cassette chromosome mec (SCCmec) types and clonal complexes are associated with low-level amoxicillin/clavulanic acid and cefalotin resistance in methicillin-resistant Staphylococcus pseudintermedius</article-title>. <source>J Antimicrob Chemother</source>
<volume>75</volume>:<fpage>508</fpage>&#x02013;<lpage>511</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkz509</pub-id><pub-id pub-id-type="pmid">31846043</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Tyson</surname>
<given-names>GH</given-names></string-name>, <string-name><surname>Ceric</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Guag</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nemser</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Borenstein</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Slavic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lippert</surname>
<given-names>S</given-names></string-name>, <string-name><surname>McDowell</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Krishnamurthy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Korosec</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2021</year>. <article-title>Genomics accurately predicts antimicrobial resistance in Staphylococcus pseudintermedius collected as part of Vet-LIRN resistance monitoring</article-title>. <source>Vet Microbiol</source>
<volume>254</volume>:<fpage>109006</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2021.109006</pub-id><pub-id pub-id-type="pmid">33581494</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Wegener</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Broens</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Zomer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Spaninks</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wagenaar</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Duim</surname>
<given-names>B</given-names></string-name></person-group>. <year>2018</year>. <article-title>Comparative genomics of phenotypic antimicrobial resistances in methicillin-resistant Staphylococcus pseudintermedius of canine origin</article-title>. <source>Vet Microbiol</source>
<volume>225</volume>:<fpage>125</fpage>&#x02013;<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2018.09.013</pub-id><pub-id pub-id-type="pmid">30322524</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Ceric</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Tyson</surname>
<given-names>GH</given-names></string-name>, <string-name><surname>Goodman</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Prarat</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cui</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Peak</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Scaria</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Antony</surname>
<given-names>L</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2019</year>. <article-title>Enhancing the one health initiative by using whole genome sequencing to monitor antimicrobial resistance of animal pathogens: Vet-LIRN collaborative project with veterinary diagnostic laboratories in United States and Canada</article-title>. <source>BMC Vet Res</source>
<volume>15</volume>:<elocation-id>130</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s12917-019-1864-2</pub-id><pub-id pub-id-type="pmid">31060608</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>USDA</collab></person-group>. <year>2024</year>. <source>USDA APHIS VS National animal health laboratory network (NAHLN) antimicrobial resistance pilot project</source>. <publisher-name>USDA APHIS</publisher-name>.</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Timme</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Wolfgang</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Balkey</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Venkata</surname>
<given-names>SLG</given-names></string-name>, <string-name><surname>Randolph</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Allard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Strain</surname>
<given-names>E</given-names></string-name></person-group>. <year>2020</year>. <article-title>Optimizing open data to support one health: best practices to ensure interoperability of genomic data from bacterial pathogens</article-title>. <source>One Health Outlook</source>
<volume>2</volume>:<elocation-id>20</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s42522-020-00026-3</pub-id><pub-id pub-id-type="pmid">33103064</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="report">
<person-group person-group-type="author"><collab>USDA</collab></person-group>. <year>2020</year>. <article-title>USDA APHIS VS National animal health laboratory network (NAHLN) antimicrobial resistance pilot project year 3 report: 2020</article-title></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Magiorakos</surname>
<given-names>A-P</given-names></string-name>, <string-name><surname>Srinivasan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Carey</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Carmeli</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Falagas</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Giske</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Harbarth</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hindler</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Kahlmeter</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Olsson-Liljequist</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Paterson</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Rice</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Stelling</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Struelens</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Vatopoulos</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Weber</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Monnet</surname>
<given-names>DL</given-names></string-name></person-group>. <year>2012</year>. <article-title>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title>. <source>Clin Microbiol Infect</source>
<volume>18</volume>:<fpage>268</fpage>&#x02013;<lpage>281</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03570.x</pub-id><pub-id pub-id-type="pmid">21793988</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Souvorov</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Agarwala</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Lipman</surname>
<given-names>DJ</given-names></string-name></person-group>. <year>2018</year>. <article-title>SKESA: strategic k-mer extension for scrupulous assemblies</article-title>. <source>Genome Biol</source>
<volume>19</volume>:<elocation-id>153</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s13059-018-1540-z</pub-id><pub-id pub-id-type="pmid">30286803</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Tonkin-Hill</surname>
<given-names>G</given-names></string-name>, <string-name><surname>MacAlasdair</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ruis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Weimann</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Horesh</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lees</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Gladstone</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Lo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Beaudoin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Floto</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Frost</surname>
<given-names>SDW</given-names></string-name>, <string-name><surname>Corander</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bentley</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Parkhill</surname>
<given-names>J</given-names></string-name></person-group>. <year>2020</year>. <article-title>Producing polished prokaryotic pangenomes with the Panaroo pipeline</article-title>. <source>Genome Biol</source>
<volume>21</volume>:<elocation-id>180</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s13059-020-02090-4</pub-id><pub-id pub-id-type="pmid">32698896</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Jolley</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Maiden</surname>
<given-names>MCJ</given-names></string-name></person-group>. <year>2010</year>. <article-title>BIGSdb: scalable analysis of bacterial genome variation at the population level</article-title>. <source>BMC Bioinformatics</source>
<volume>11</volume>:<elocation-id>595</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/1471-2105-11-595</pub-id><pub-id pub-id-type="pmid">21143983</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Katoh</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Standley</surname>
<given-names>DM</given-names></string-name></person-group>. <year>2013</year>. <article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title>. <source>Mol Biol Evol</source>
<volume>30</volume>:<fpage>772</fpage>&#x02013;<lpage>780</lpage>. doi:<pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id><pub-id pub-id-type="pmid">23329690</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Castresana</surname>
<given-names>J</given-names></string-name></person-group>. <year>2000</year>. <article-title>Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis</article-title>. <source>Mol Biol Evol</source>
<volume>17</volume>:<fpage>540</fpage>&#x02013;<lpage>552</lpage>. doi:<pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a026334</pub-id><pub-id pub-id-type="pmid">10742046</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Talavera</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Castresana</surname>
<given-names>J</given-names></string-name></person-group>. <year>2007</year>. <article-title>Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments</article-title>. <source>Syst Biol</source>
<volume>56</volume>:<fpage>564</fpage>&#x02013;<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1080/10635150701472164</pub-id><pub-id pub-id-type="pmid">17654362</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Minh</surname>
<given-names>BQ</given-names></string-name>, <string-name><surname>Schmidt</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Chernomor</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Schrempf</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Woodhams</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>von Haeseler</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lanfear</surname>
<given-names>R</given-names></string-name></person-group>. <year>2020</year>. <article-title>IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era</article-title>. <source>Mol Biol Evol</source>
<volume>37</volume>:<fpage>1530</fpage>&#x02013;<lpage>1534</lpage>. doi:<pub-id pub-id-type="doi">10.1093/molbev/msaa015</pub-id><pub-id pub-id-type="pmid">32011700</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Letunic</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Bork</surname>
<given-names>P</given-names></string-name></person-group>. <year>2021</year>. <article-title>Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation</article-title>. <source>Nucleic Acids Res</source>
<volume>49</volume>:<fpage>W293</fpage>&#x02013;<lpage>W296</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkab301</pub-id><pub-id pub-id-type="pmid">33885785</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Tonkin-Hill</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lees</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Bentley</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Frost</surname>
<given-names>SDW</given-names></string-name>, <string-name><surname>Corander</surname>
<given-names>J</given-names></string-name></person-group>. <year>2018</year>. <article-title>RhierBAPS: an R implementation of the population clustering algorithm hierBAPS</article-title>. <source>Wellcome Open Res</source>
<volume>3</volume>:<elocation-id>93</elocation-id>. doi:<pub-id pub-id-type="doi">10.12688/wellcomeopenres.14694.1</pub-id><pub-id pub-id-type="pmid">30345380</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Carattoli</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zankari</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Garc&#x000ed;a-Fern&#x000e1;ndez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Voldby Larsen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lund</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Villa</surname>
<given-names>L</given-names></string-name>, <string-name><surname>M&#x000f8;ller Aarestrup</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hasman</surname>
<given-names>H</given-names></string-name></person-group>. <year>2014</year>. <article-title>In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>58</volume>:<fpage>3895</fpage>&#x02013;<lpage>3903</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.02412-14</pub-id><pub-id pub-id-type="pmid">24777092</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Petit</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Read</surname>
<given-names>TD</given-names></string-name></person-group>. <year>2018</year>. <article-title>Staphylococcus aureus viewed from the perspective of 40,000+ genomes</article-title> . <source>PeerJ</source>
<volume>6</volume>:<elocation-id>e5261</elocation-id>. doi:<pub-id pub-id-type="doi">10.7717/peerj.5261</pub-id><pub-id pub-id-type="pmid">30013858</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Worthing</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Schwendener</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Perreten</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Saputra</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Coombs</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Pang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Abraham</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Trott</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Norris</surname>
<given-names>JM</given-names></string-name></person-group>. <year>2018</year>. <article-title>Characterization of staphylococcal cassette chromosome mec elements from methicillin-resistant Staphylococcus pseudintermedius infections in Australian animals</article-title>. <source>mSphere</source>
<volume>3</volume>:<elocation-id>e00491-18</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mSphere.00491-18</pub-id><pub-id pub-id-type="pmid">30404937</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Phophi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Abouelkhair</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zehr</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kania</surname>
<given-names>SA</given-names></string-name></person-group>. <year>2023</year>. <article-title>Temporal changes in antibiotic resistance and population structure of methicillin-resistant Staphylococcus pseudintermedius between 2010 and 2021 in the United States</article-title>. <source>Comp Immunol Microbiol Infect Dis</source>
<volume>100</volume>:<fpage>102028</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cimid.2023.102028</pub-id><pub-id pub-id-type="pmid">37517211</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>F&#x000e0;bregas</surname>
<given-names>N</given-names></string-name>, <string-name><surname>P&#x000e9;rez</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Vi&#x000f1;es</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cusc&#x000f3;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Migura-Garc&#x000ed;a</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ferrer</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Francino</surname>
<given-names>O</given-names></string-name></person-group>. <year>2023</year>. <article-title>Diverse populations of Staphylococcus pseudintermedius colonize the skin of healthy dogs</article-title>. <source>Microbiol Spectr</source>
<volume>11</volume>:<elocation-id>e0339322</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/spectrum.03393-22</pub-id><pub-id pub-id-type="pmid">36786649</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bergot</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Martins-Simoes</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kilian</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ch&#x000e2;tre</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Worthing</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Norris</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Madec</surname>
<given-names>J-Y</given-names></string-name>, <string-name><surname>Laurent</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Haenni</surname>
<given-names>M</given-names></string-name></person-group>. <year>2018</year>. <article-title>Evolution of the population structure of Staphylococcus pseudintermedius in France</article-title>. <source>Front Microbiol</source>
<volume>9</volume>:<elocation-id>3055</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.03055</pub-id><pub-id pub-id-type="pmid">30619143</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Duim</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Verstappen</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Broens</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Laarhoven</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>van Duijkeren</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hordijk</surname>
<given-names>J</given-names></string-name>, <string-name><surname>de Heus</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Spaninks</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Timmerman</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Wagenaar</surname>
<given-names>JA</given-names></string-name></person-group>. <year>2016</year>. <article-title>Changes in the population of methicillin-resistant Staphylococcus pseudintermedius and dissemination of antimicrobial-resistant phenotypes in the Netherlands</article-title>. <source>J Clin Microbiol</source>
<volume>54</volume>:<fpage>283</fpage>&#x02013;<lpage>288</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.01288-15</pub-id><pub-id pub-id-type="pmid">26582835</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gr&#x000f6;nthal</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Eklund</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Thomson</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Piiparinen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sironen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Rantala</surname>
<given-names>M</given-names></string-name></person-group>. <year>2017</year>. <article-title>Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland</article-title>. <source>J Antimicrob Chemother</source>
<volume>72</volume>:<fpage>1021</fpage>&#x02013;<lpage>1030</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkw559</pub-id><pub-id pub-id-type="pmid">28065889</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Morais</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Costa</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Leal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ramos</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Andrade</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Abrantes</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pomba</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Couto</surname>
<given-names>I</given-names></string-name></person-group>. <year>2023</year>. <article-title>Genetic diversity and antimicrobial resistance profiles of Staphylococcus pseudintermedius associated with skin and soft-tissue infections in companion animals in Lisbon, Portugal</article-title>. <source>Front Microbiol</source>
<volume>14</volume>:<elocation-id>1167834</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2023.1167834</pub-id><pub-id pub-id-type="pmid">37138637</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kizerwetter-&#x0015a;wida</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chrobak-Chmiel</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rzewuska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Binek</surname>
<given-names>M</given-names></string-name></person-group>. <year>2017</year>. <article-title>Changes in the population structure of canine methicillin-resistant Staphylococcus pseudintermedius in Poland</article-title>. <source>Vet Microbiol</source>
<volume>208</volume>:<fpage>106</fpage>&#x02013;<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2017.07.025</pub-id><pub-id pub-id-type="pmid">28888624</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Pires Dos Santos</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Damborg</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Moodley</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Guardabassi</surname>
<given-names>L</given-names></string-name></person-group>. <year>2016</year>. <article-title>Systematic review on global epidemiology of methicillin-resistant Staphylococcus pseudintermedius: inference of population structure from multilocus sequence typing data</article-title>. <source>Front Microbiol</source>
<volume>7</volume>:<elocation-id>1599</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.01599</pub-id><pub-id pub-id-type="pmid">27803691</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mao</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>H</given-names></string-name></person-group>. <year>2023</year>. <article-title>Global trend of antimicrobial resistance in common bacterial pathogens in response to antibiotic consumption</article-title>. <source>J Hazard Mater</source>
<volume>442</volume>:<fpage>130042</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhazmat.2022.130042</pub-id><pub-id pub-id-type="pmid">36182890</pub-id>
</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Costa</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Ribeiro</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Serrano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Oliveira</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Leal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pomba</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Couto</surname>
<given-names>I</given-names></string-name></person-group>. <year>2022</year>. <article-title>Staphylococcus aureus causing skin and soft tissue infections in companion animals: antimicrobial resistance profiles and clonal lineages</article-title>. <source>Antibiotics (Basel)</source>
<volume>11</volume>:<elocation-id>599</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/antibiotics11050599</pub-id><pub-id pub-id-type="pmid">35625243</pub-id>
</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Duquette</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Nuttall</surname>
<given-names>TJ</given-names></string-name></person-group>. <year>2004</year>. <article-title>Methicillin-resistant Staphylococcus aureus in dogs and cats: an emerging problem?</article-title>
<source>J Small Anim Pract</source>
<volume>45</volume>:<fpage>591</fpage>&#x02013;<lpage>597</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1748-5827.2004.tb00180.x</pub-id><pub-id pub-id-type="pmid">15600269</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Boost</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>O&#x02019;Donoghue</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>James</surname>
<given-names>A</given-names></string-name></person-group>. <year>2008</year>. <article-title>Prevalence of Staphylococcus aureus carriage among dogs and their owners</article-title>. <source>Epidemiol Infect</source>
<volume>136</volume>:<fpage>953</fpage>&#x02013;<lpage>964</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0950268807009326</pub-id><pub-id pub-id-type="pmid">17678561</pub-id>
</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>van Duijkeren</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Wolfhagen</surname>
<given-names>MJHM</given-names></string-name>, <string-name><surname>Box</surname>
<given-names>ATA</given-names></string-name>, <string-name><surname>Heck</surname>
<given-names>MEOC</given-names></string-name>, <string-name><surname>Wannet</surname>
<given-names>WJB</given-names></string-name>, <string-name><surname>Fluit</surname>
<given-names>AC</given-names></string-name></person-group>. <year>2004</year>. <article-title>Human-to-dog transmission of methicillin-resistant Staphylococcus aureus</article-title>. <source>Emerg Infect Dis</source>
<volume>10</volume>:<fpage>2235</fpage>&#x02013;<lpage>2237</lpage>. doi:<pub-id pub-id-type="doi">10.3201/eid1012.040387</pub-id><pub-id pub-id-type="pmid">15663871</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bell</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Turnidge</surname>
<given-names>JD</given-names></string-name>, <collab>SENTRY APAC</collab></person-group>. <year>2002</year>. <article-title>High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>46</volume>:<fpage>879</fpage>&#x02013;<lpage>881</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.46.3.880-882.2002</pub-id><pub-id pub-id-type="pmid">11850278</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chuang</surname>
<given-names>Y-Y</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y-C</given-names></string-name></person-group>. <year>2013</year>. <article-title>Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia</article-title>. <source>Lancet Infect Dis</source>
<volume>13</volume>:<fpage>698</fpage>&#x02013;<lpage>708</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(13)70136-1</pub-id><pub-id pub-id-type="pmid">23827369</pub-id>
</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>European Centre for Disease Prevention and Control</collab></person-group>. <year>2023</year>. <source>Antimicrobial resistance surveillance in Europe 2023 - 2021 data</source>. <publisher-name>European Centre for Disease Prevention and Control</publisher-name>.</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Shabbir</surname>
<given-names>MAB</given-names></string-name>, <string-name><surname>Shabbir</surname>
<given-names>MZ</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Mahmood</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sajid</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Maan</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Naveed</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Hao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>Z</given-names></string-name></person-group>. <year>2019</year>. <article-title>CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens</article-title>. <source>Ann Clin Microbiol Antimicrob</source>
<volume>18</volume>:<elocation-id>21</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s12941-019-0317-x</pub-id><pub-id pub-id-type="pmid">31277669</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Tao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>W</given-names></string-name></person-group>. <year>2022</year>. <article-title>The application of the CRISPR-Cas system in antibiotic resistance</article-title>. <source>Infect Drug Resist</source>
<volume>15</volume>:<fpage>4155</fpage>&#x02013;<lpage>4168</lpage>. doi:<pub-id pub-id-type="doi">10.2147/IDR.S370869</pub-id><pub-id pub-id-type="pmid">35942309</pub-id>
</mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Wu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Battalapalli</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hakeem</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Selamneni</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Draz</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>Z</given-names></string-name></person-group>. <year>2021</year>. <article-title>Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections</article-title>. <source>J Nanobiotechnology</source>
<volume>19</volume>:<elocation-id>401</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s12951-021-01132-8</pub-id><pub-id pub-id-type="pmid">34863214</pub-id>
</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sampson</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Napier</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Schroeder</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Louwen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chin</surname>
<given-names>C-Y</given-names></string-name>, <string-name><surname>Ratner</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Llewellyn</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Laroui</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Merlin</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Endtz</surname>
<given-names>HP</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>DS</given-names></string-name></person-group>. <year>2014</year>. <article-title>A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>111</volume>:<fpage>11163</fpage>&#x02013;<lpage>11168</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1323025111</pub-id><pub-id pub-id-type="pmid">25024199</pub-id>
</mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>LZ</given-names></string-name>, <string-name><surname>Vederas</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Zuber</surname>
<given-names>P</given-names></string-name></person-group>. <year>1999</year>. <article-title>Genes of the sbo-alb locus of Bacillus subtilis are required for production of the antilisterial bacteriocin subtilosin</article-title>. <source>J Bacteriol</source>
<volume>181</volume>:<fpage>7346</fpage>&#x02013;<lpage>7355</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.181.23.7346-7355.1999</pub-id><pub-id pub-id-type="pmid">10572140</pub-id>
</mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Fl&#x000fc;he</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Knappe</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Gattner</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Sch&#x000e4;fer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Burghaus</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Linne</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Marahiel</surname>
<given-names>MA</given-names></string-name></person-group>. <year>2012</year>. <article-title>The radical SAM enzyme AlbA catalyzes thioether bond formation in subtilosin A</article-title>. <source>Nat Chem Biol</source>
<volume>8</volume>:<fpage>350</fpage>&#x02013;<lpage>357</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.798</pub-id><pub-id pub-id-type="pmid">22366720</pub-id>
</mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Hehn</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zuber</surname>
<given-names>P</given-names></string-name></person-group>. <year>2000</year>. <article-title>Mutational analysis of the sbo-alb locus of Bacillus subtilis: identification of genes required for subtilosin production and immunity</article-title>. <source>J Bacteriol</source>
<volume>182</volume>:<fpage>3266</fpage>&#x02013;<lpage>3273</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.182.11.3266-3273.2000</pub-id><pub-id pub-id-type="pmid">10809709</pub-id>
</mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Shelburne</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>An</surname>
<given-names>FY</given-names></string-name>, <string-name><surname>Dholpe</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ramamoorthy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lopatin</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Lantz</surname>
<given-names>MS</given-names></string-name></person-group>. <year>2006</year>. <article-title>The spectrum of antimicrobial activity of the bacteriocin subtilosin A</article-title>. <source>J Antimicrob Chemother</source>
<volume>59</volume>:<fpage>297</fpage>&#x02013;<lpage>300</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkl495</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Alessandrini</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mercuri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Martella</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ferrara</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Simonetti</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Trifir&#x000f2;</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Emanuele</surname>
<given-names>E</given-names></string-name></person-group>. <year>2023</year>. <article-title>Topical application of bacteriocins from Bacillus subtilis promotes Staphylococcus aureus decolonization in acneic skin and improves the clinical appearance of mild-to-moderate acne</article-title>. <source>Adv Dermatol Allergol</source>
<volume>40</volume>:<fpage>115</fpage>&#x02013;<lpage>118</lpage>. doi:<pub-id pub-id-type="doi">10.5114/ada.2022.124108</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Madec</surname>
<given-names>J-Y</given-names></string-name>, <string-name><surname>Bousquet-M&#x000e9;lou</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Haenni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ferran</surname>
<given-names>AA</given-names></string-name></person-group>. <year>2021</year>. <article-title>Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate</article-title>. <source>Sci Rep</source>
<volume>11</volume>:<fpage>6225</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-021-85722-4</pub-id><pub-id pub-id-type="pmid">33737602</pub-id>
</mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Leistikow</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>May</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Suh</surname>
<given-names>WS</given-names></string-name>, <string-name><surname>Asensio</surname>
<given-names>GV</given-names></string-name>, <string-name><surname>Currie</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Hristova</surname>
<given-names>KR</given-names></string-name></person-group>. <year>2023</year>. <article-title>Bacillus subtilis derived lipopeptides disrupt quorum sensing and biofilm assembly in Staphylococcus aureus</article-title>. <source>bioRxiv</source>. doi:<pub-id pub-id-type="doi">10.1101/2023.08.24.554662</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lamers</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Muthukrishnan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Castoe</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Tafur</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cole</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Parkinson</surname>
<given-names>CL</given-names></string-name></person-group>. <year>2012</year>. <article-title>Phylogenetic relationships among Staphylococcus species and refinement of cluster groups based on multilocus data</article-title>. <source>BMC Evol Biol</source>
<volume>12</volume>:<elocation-id>171</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/1471-2148-12-171</pub-id><pub-id pub-id-type="pmid">22950675</pub-id>
</mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>W</given-names></string-name></person-group>. <year>2021</year>. <article-title>Current advancements in sactipeptide natural products</article-title>. <source>Front Chem</source>
<volume>9</volume>:<fpage>595991</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fchem.2021.595991</pub-id><pub-id pub-id-type="pmid">34095082</pub-id>
</mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Yan</surname>
<given-names>F</given-names></string-name>, <string-name><surname>LaMarre</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>R&#x000f6;hrich</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wiesner</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jomaa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mankin</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Fujimori</surname>
<given-names>DG</given-names></string-name></person-group>. <year>2010</year>. <article-title>RlmN and Cfr are radical SAM enzymes involved in methylation of ribosomal RNA</article-title>. <source>J Am Chem Soc</source>
<volume>132</volume>:<fpage>3953</fpage>&#x02013;<lpage>3964</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ja910850y</pub-id><pub-id pub-id-type="pmid">20184321</pub-id>
</mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Ledger</surname>
<given-names>EVK</given-names></string-name>, <string-name><surname>Lau</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tate</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>AM</given-names></string-name></person-group>. <year>2023</year>. <article-title>XerC is required for the repair of antibiotic- and immune-mediated DNA damage in Staphylococcus aureus</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>67</volume>:<elocation-id>e0120622</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/aac.01206-22</pub-id><pub-id pub-id-type="pmid">36802166</pub-id>
</mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Durrant</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Fanton</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tycko</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hinks</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chandrasekaran</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Perry</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Schaepe</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>PP</given-names></string-name>, <string-name><surname>Lotfy</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bassik</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Bintu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bhatt</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>PD</given-names></string-name></person-group>. <year>2023</year>. <article-title>Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome</article-title>. <source>Nat Biotechnol</source>
<volume>41</volume>:<fpage>488</fpage>&#x02013;<lpage>499</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41587-022-01494-w</pub-id><pub-id pub-id-type="pmid">36217031</pub-id>
</mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Dwyer</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Belenky</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>MacDonald</surname>
<given-names>IC</given-names></string-name>, <string-name><surname>Martell</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>CTY</given-names></string-name>, <string-name><surname>Lobritz</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Braff</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Schwarz</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Pati</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vercruysse</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ralifo</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Allison</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Khalil</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Ting</surname>
<given-names>AY</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>JJ</given-names></string-name></person-group>. <year>2014</year>. <article-title>Antibiotics induce redox-related physiological alterations as part of their lethality</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>111</volume>:<fpage>E2100</fpage>&#x02013;<lpage>E2109</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1401876111</pub-id><pub-id pub-id-type="pmid">24803433</pub-id>
</mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Si</surname>
<given-names>M</given-names></string-name></person-group>. <year>2019</year>. <article-title>Myo-inositol-1-phosphate synthase (Ino-1) functions as a protection mechanism in Corynebacterium glutamicum under oxidative stress</article-title>. <source>Microbiologyopen</source>
<volume>8</volume>:<elocation-id>e00721</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/mbo3.721</pub-id><pub-id pub-id-type="pmid">30270521</pub-id>
</mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Cikman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aydin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gulhan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Karakecili</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Kurtoglu</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Yuksekkaya</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Parlak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gultepe</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Cicek</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Bilman</surname>
<given-names>FB</given-names></string-name>, <string-name><surname>Ciftci</surname>
<given-names>IH</given-names></string-name>, <string-name><surname>Kara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atmaca</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ozekinci</surname>
<given-names>T</given-names></string-name></person-group>. <year>2019</year>. <article-title>Absence of the mecC gene in methicillin-resistant Staphylococcus aureus isolated from various clinical samples: the first multi-centered study in Turkey</article-title>. <source>J Infect Public Health</source>
<volume>12</volume>:<fpage>528</fpage>&#x02013;<lpage>533</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jiph.2019.01.063</pub-id><pub-id pub-id-type="pmid">30745200</pub-id>
</mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Elhassan</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Ozbak</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Hemeg</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Elmekki</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>LM</given-names></string-name></person-group>. <year>2015</year>. <article-title>Absence of the mecA gene in methicillin resistant Staphylococcus aureus isolated from different clinical specimens in Shendi City, Sudan</article-title>. <source>Biomed Res Int</source>
<volume>2015</volume>:<elocation-id>895860</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2015/895860</pub-id><pub-id pub-id-type="pmid">26290877</pub-id>
</mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gonz&#x000e1;lez-V&#x000e1;zquez</surname>
<given-names>R</given-names></string-name>, <string-name><surname>C&#x000f3;rdova-Espinoza</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Escamilla-Guti&#x000e9;rrez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Herrera-Cuevas</surname>
<given-names>MDR</given-names></string-name>, <string-name><surname>Gonz&#x000e1;lez-V&#x000e1;zquez</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Esquivel-Campos</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>L&#x000f3;pez-Pelcastre</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Torres-Cubillas</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Mayorga-Reyes</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mendoza-P&#x000e9;rez</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Guti&#x000e9;rrez-Nava</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Giono-Cerezo</surname>
<given-names>S</given-names></string-name></person-group>. <year>2024</year>. <article-title>Detection of mecA genes in hospital-acquired MRSA and SOSA strains associated with biofilm formation</article-title>. <source>Pathogens</source>
<volume>13</volume>:<elocation-id>212</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/pathogens13030212</pub-id><pub-id pub-id-type="pmid">38535555</pub-id>
</mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lu</surname>
<given-names>C-H</given-names></string-name>, <string-name><surname>McCloskey</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>F-R</given-names></string-name>, <string-name><surname>Nakayasu</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L-Q</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>Z-Q</given-names></string-name></person-group>. <year>2020</year>. <article-title>Fic proteins inhibit the activity of topoisomerase IV by AMPylation in diverse bacteria</article-title>. <source>Front Microbiol</source>
<volume>11</volume>:<elocation-id>2084</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2020.02084</pub-id><pub-id pub-id-type="pmid">32983060</pub-id>
</mixed-citation></ref></ref-list></back></article>